Armada Acquisition Corp. I (AACI) 10-Q21 Aug 242024 Q3 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	9 Months Ended
Cover - shares	Jun. 30, 2024	Aug. 15, 2024
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2024
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--09-30
Entity File Number	001-40742
Entity Registrant Name	Armada Acquisition Corp. I
Entity Central Index Key	0001844817
Entity Tax Identification Number	85-3810850
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	1760 Market Street
Entity Address, Address Line Two	Suite 602
Entity Address, City or Town	Philadelphia
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19103
City Area Code	215
Local Phone Number	543-6886
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		5,826,796
Units Each Consisting Of One Share Of Common Stock And Onehalf Of One Redeemable Warrant [Member]
Title of 12(b) Security	Units, each consisting of one share of Common Stock and one-half of one Redeemable Warrant
Trading Symbol	AACIU
Security Exchange Name	NASDAQ
Common Stock Par Value 0. 0001 Per Share [Member]
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	AACI
Security Exchange Name	NASDAQ
Warrants Each Exercisable For One Share Of Common Stock For 11. 50 Per Share [Member]
Title of 12(b) Security	Warrants, each exercisable for one share of Common Stock for $11.50 per share
Trading Symbol	AACIW
Security Exchange Name	NASDAQ

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2024	Sep. 30, 2023
Assets
Cash	$ 13,242	$ 60,284
Prepaid expenses	41,788	33,605
Total current assets	55,030	93,889
Cash held in Trust Account	16,126,337	25,324,028
Total Assets	16,181,367	25,417,917
Current liabilities:
Accounts payable	6,035,757	4,708,050
Franchise tax payable	46,000	12,100
Income tax payable	50,026	10,783
Subscription agreements liability, net	354,503	0
Excise tax payable	1,395,596	1,291,751
Total current liabilities	10,938,608	8,587,123
Commitments and Contingencies (Note 5)
Common stock subject to possible redemption, 1,417,687 and 2,363,349 shares at redemption value of approximately $11.31and $10.71 per share at June 30, 2024 and September 30, 2023, respectively	16,040,786	25,316,806
Stockholders' Deficit:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.0001 par value; 100,000,000 shares authorized, 5,709,500 shares issued and outstanding (excluding 1,417,687 and 2,363,349 shares subject to possible redemption) at June 30, 2024 and September 30, 2023, respectively	570	570
Additional paid-in capital	261,161	0
Accumulated deficit	(11,059,758)	(8,486,582)
Total Stockholders' Deficit	(10,798,027)	(8,486,012)
Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders' Deficit	16,181,367	25,417,917
Related Party [Member]
Current liabilities:
Promissory Notes-Related Party	$ 3,056,726	$ 2,564,439

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2024	Sep. 30, 2023
Statement of Financial Position [Abstract]
Common stock subject to possible redemption, shares	1,417,687	2,363,349
Common stock subject to possible redemption, redemption value per share	$ 11.31	$ 10.71
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	1,000,000	1,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	5,709,500	5,709,500
Common Stock, Shares, Outstanding	5,709,500	5,709,500

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
CONDENSED STATEMENTS OF OPERATIONS - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Formation and operating costs	$ 844,718	$ 775,911	$ 1,876,158	$ 1,960,998
Stock-based compensation	526,209	134,363	601,809	190,289
Loss from operations	(1,370,927)	(910,274)	(2,477,967)	(2,151,287)
Other (expense) income
Interest expense	(220,050)	0	(344,248)	0
Trust interest income	206,289	433,066	811,281	2,697,147
Total other (expense) income, net	(13,761)	433,066	467,033	2,697,147
Loss before provision for income taxes	(1,384,688)	(477,208)	(2,010,934)	545,860
Provision for income taxes	(38,407)	(82,376)	(153,321)	(525,560)
Net (loss) income	(1,423,095)	(559,584)	(2,164,255)	20,300
Common Stock [Member]
Other (expense) income
Net (loss) income	$ (1,140,024)	$ (346,585)	$ (1,625,155)	$ 8,004
Basic weighted average shares outstanding	5,709,500	5,709,500	5,709,500	5,709,500
Diluted weighted average shares outstanding	5,709,500	5,709,500	5,709,500	5,709,500
Basic net (loss) income per share	$ (0.2)	$ (0.06)	$ (0.28)	$ 0
Diluted net (loss) income per share	$ (0.2)	$ (0.06)	$ (0.28)	$ 0
Common Stock [Member] \| Common stock subject to possible redemption [Member]
Other (expense) income
Basic weighted average shares outstanding	1,417,687	3,508,852	1,893,969	8,770,367
Diluted weighted average shares outstanding	1,417,687	3,508,852	1,893,969	8,770,367
Basic net (loss) income per share	$ (0.2)	$ (0.06)	$ (0.28)	$ 0
Diluted net (loss) income per share	$ (0.2)	$ (0.06)	$ (0.28)	$ 0
Common Stock [Member] \| Non-redeemable common stock [Member]
Other (expense) income
Basic weighted average shares outstanding	5,709,500	5,709,500	5,709,500	5,709,500
Diluted weighted average shares outstanding	5,709,500	5,709,500	5,709,500	5,709,500
Basic net (loss) income per share	$ (0.2)	$ (0.06)	$ (0.28)	$ 0
Diluted net (loss) income per share	$ (0.2)	$ (0.06)	$ (0.28)	$ 0

CONDENSED STATEMENTS OF CHANGES

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Total	Subscription Agreement [Member] Sponsor [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] Subscription Agreement [Member] Sponsor [Member]	Accumulated Deficit [Member]
Beginning balance, value at Sep. 30, 2022	$ (3,149,327)		$ 570	$ 941,796		$ (4,091,693)
Beginning balance, shares at Sep. 30, 2022			5,709,500
Stock-based compensation	27,963			27,963
Subsequent remeasurement of common stock subject to possible redemption	(2,479,343)					(2,479,343)
Net Income (Loss)	607,027					607,027
Ending balance, value at Dec. 31, 2022	(4,993,680)		$ 570	969,759		(5,964,009)
Ending balance, shares at Dec. 31, 2022			5,709,500
Beginning balance, value at Sep. 30, 2022	(3,149,327)		$ 570	941,796		(4,091,693)
Beginning balance, shares at Sep. 30, 2022			5,709,500
Excise tax payable on redemption	1,170,799
Net Income (Loss)	20,300		$ 8,004
Ending balance, value at Jun. 30, 2023	(7,587,085)		$ 570	134,363		(7,722,018)
Ending balance, shares at Jun. 30, 2023			5,709,500
Beginning balance, value at Dec. 31, 2022	(4,993,680)		$ 570	969,759		(5,964,009)
Beginning balance, shares at Dec. 31, 2022			5,709,500
Stock-based compensation	27,963			27,963
Subsequent remeasurement of common stock subject to possible redemption	(669,074)					(669,074)
Excise tax payable on redemption	(1,170,799)			(997,722)		(173,077)
Capital contribution made by Sponsor related to the stockholder non-redemption agreements				1,102,909
Cost of raising capital related to the stockholder non-redemption agreements				(1,102,909)
Net Income (Loss)	(27,143)					(27,143)
Ending balance, value at Mar. 31, 2023	(6,832,733)		$ 570	0		(6,833,303)
Ending balance, shares at Mar. 31, 2023			5,709,500
Stock-based compensation	134,363			134,363
Subsequent remeasurement of common stock subject to possible redemption	(329,131)					(329,131)
Net Income (Loss)	(559,584)		$ (346,585)			(559,584)
Ending balance, value at Jun. 30, 2023	(7,587,085)		$ 570	134,363		(7,722,018)
Ending balance, shares at Jun. 30, 2023			5,709,500
Beginning balance, value at Sep. 30, 2023	$ (8,486,012)		$ 570	0		(8,486,582)
Beginning balance, shares at Sep. 30, 2023	5,709,500		5,709,500
Stock-based compensation	$ 50,400			50,400
Proceeds allocated to Sponsor Shares for subscription agreement liability (see note 4)		$ 108,634			$ 108,634
Subsequent remeasurement of common stock subject to possible redemption	(467,884)			(159,034)		(308,850)
Net Income (Loss)	(360,314)					(360,314)
Ending balance, value at Dec. 31, 2023	(9,155,176)		$ 570	0		(9,155,746)
Ending balance, shares at Dec. 31, 2023			5,709,500
Beginning balance, value at Sep. 30, 2023	$ (8,486,012)		$ 570	0		(8,486,582)
Beginning balance, shares at Sep. 30, 2023	5,709,500		5,709,500
Excise tax payable on redemption	$ 103,845
Net Income (Loss)	(2,164,255)		$ (1,625,155)
Ending balance, value at Jun. 30, 2024	$ (10,798,027)		$ 570	261,161		(11,059,758)
Ending balance, shares at Jun. 30, 2024	5,709,500		5,709,500
Beginning balance, value at Dec. 31, 2023	$ (9,155,176)		$ 570	0		(9,155,746)
Beginning balance, shares at Dec. 31, 2023			5,709,500
Stock-based compensation	25,200			25,200
Proceeds allocated to Sponsor Shares for subscription agreement liability (see note 4)		325,826			325,826
Subsequent remeasurement of common stock subject to possible redemption	(347,252)			(347,252)
Excise tax payable on redemption	(103,845)			(3,774)		(100,071)
Net Income (Loss)	(380,846)					(380,846)
Ending balance, value at Mar. 31, 2024	(9,636,093)		$ 570	0		(9,636,663)
Ending balance, shares at Mar. 31, 2024			5,709,500
Stock-based compensation	526,209			526,209
Proceeds allocated to Sponsor Shares for subscription agreement liability (see note 4)		$ 28,292			$ 28,292
Subsequent remeasurement of common stock subject to possible redemption	(293,340)			(293,340)
Net Income (Loss)	(1,423,095)		$ (1,140,024)			(1,423,095)
Ending balance, value at Jun. 30, 2024	$ (10,798,027)		$ 570	$ 261,161		$ (11,059,758)
Ending balance, shares at Jun. 30, 2024	5,709,500		5,709,500

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	Jun. 30, 2024	Jun. 30, 2023
Cash Flows from Operating Activities:
Net Income (Loss)	$ (2,164,255)	$ 20,300
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Interest earned on cash and marketable securities held in Trust Account	(811,281)	(2,697,147)
Interest expense	344,248	0
Stock-based compensation	601,809	190,289
Changes in current assets and liabilities:
Prepaid expenses	(8,183)	25,706
Accounts payable and accrued expenses	1,327,705	979,793
Income tax payable	39,243	117,873
Franchise tax payable	33,900	(28,000)
Net cash used in operating activities	(636,814)	(1,391,186)
Cash Flows from Investing Activities:
Withdrawals from trust for redemptions	10,384,496	117,079,879
Withdrawals from trust to pay for taxes	156,174	804,072
Principal deposited in Trust Account	(531,697)	(1,500,000)
Net cash provided by investing activities	10,008,973	116,383,951
Cash Flows from Financing Activities:
Proceeds from issuance of promissory note to related party	492,287	1,950,000
Proceeds from subscription agreement	473,008	0
Redemptions of shares	(10,384,496)	(117,079,879)
Net cash used in financing activities	(9,419,201)	(115,129,879)
Net change in cash	(47,042)	(137,114)
Cash, beginning of the period	60,284	177,578
Cash, end of the period	13,242	40,464
Supplemental disclosure of non-cash financing activities:
Remeasurement of common stock subject to possible redemption	1,108,476	3,477,548
Excise tax payable on redemptions	103,845	1,170,799
Income taxes paid	114,078	0
Cost of issuance of debt under subscription agreements	$ 462,751	$ 0

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended						9 Months Ended
Pay vs Performance Disclosure - USD ($)	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (1,423,095)	$ (380,846)	$ (360,314)	$ (559,584)	$ (27,143)	$ 607,027	$ (2,164,255)	$ 20,300

Insider Trading Arrangements

Insider Trading Arrangements	9 Months Ended
Insider Trading Arrangements	Jun. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Organization, Business Operatio

Organization, Business Operations and Going Concern	9 Months Ended
Organization, Business Operations and Going Concern	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Business Operations and Going Concern	Note–1 - Organization, Business Operations and Going Concern Armada Acquisition Corp. I (the “Company” or “Armada”) is a blank check company incorporated as a Delaware corporation on November 5, 2020. The Company was incorporated for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”). On December 17, 2021, the Company entered into a business combination agreement with a target business which was amended and restated on June 16, 2023, and further amended on August 4, 2023. The Company concentrated its efforts in identifying businesses in the financial services industry with particular emphasis on businesses that are providing or changing technology for traditional financial services. As of June 30, 2024, the Company had not commenced any operations. All activity for the period from November 5, 2020 (inception) through June 30, 2024, relates to the Company’s formation and the initial public offering (the “IPO”) described below, and since the closing of the IPO, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company has generated non-operating The Company’s sponsor is Armada Sponsor LLC (the “Sponsor”). The registration statement for the Company’s IPO was declared effective on August 12, 2021 (the “Effective Date”). On August 17, 2021, the Company commenced the IPO of 15,000,000 units at $10.00 per unit (the “Units”). Simultaneously with the consummation of the IPO, the Company consummated the private placement of 459,500 shares of common stock (“Private Shares”) at a price of $10.00 per share for an aggregate purchase price of $4,595,000. Transaction costs amounted to $3,537,515, consisting of $1,500,000 of underwriting commissions, and $2,037,515 of other offering costs. Following the closing of the IPO, a total of $150,000,000 ($10.00 per Unit) was held in the Trust Account (“Trust Account”). The funds held in the Trust Account are required to be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a-7 The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the value of the assets held in the Trust Account (excluding deferred underwriting commissions and taxes payable) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination successfully. In connection with any proposed Business Combination, the Company will either (1) seek stockholders approval of the initial Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against the proposed Business Combination or do not vote at all, into their pro rata share of the aggregate amount then on deposit in the Trust Account (net of taxes payable), or (2) provide its stockholders with the opportunity to sell their shares to the Company by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount equal to their pro rata share of the aggregate amount then on deposit in the Trust Account (net of taxes payable and less up to $100,000 of interest to pay dissolution expenses), in each case subject to the limitations described herein. The decision as to whether the Company will seek stockholders approval of a proposed Business Combination or will allow stockholders to sell their shares to the Company in a tender offer will be made by the Company, solely in its discretion. The shares of common stock subject to redemption are recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination (unless the proposal amending the Company charter to remove the net tangible assets requirement in connection with the Business Combination is approved and implemented at the special meeting approving the Business Combination) and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company had until February 17, 2023 (or 18 months following the IPO) to consummate a Business Combination (the “Combination Period”). On February 2, 2023, the stockholders approved an amendment to our certificate of incorporation to extend the Combination Period until August 17, 2023. On August 2, 2023, the stockholders approved a second amendment to our certificate of incorporation to extend the Combination Period for six monthly periods or until no later than February 17, 2024. On February 15, 2024, the stockholders approved a third amendment to the Company’s certificate of incorporation to extend the Combination Period for up to six On August 8, 2023, the Company deposited $70,900 into the Trust Account thereby extending the Combination Period until September 17, 2023, and on each of September 12, 2023, October 11, 2023, November 9, 2023, December 15, 2023 and January 16, 2024, the Company deposited $70,900 into the Trust Account, thereby extending the Combination Period for five additional months or until February 17, 2024. On February 13, 2024, the Company deposited $49,619 into the Trust Account thereby extending the Combination Period until March 17, 2024, and on each of March 13, 2024 and April 16, 2024, May 17, 2024, June 17, 2024 and July 16, 2024, the Company deposited $49,619 into the Trust Account thereby extending the Combination Period until August 17, 2024. However, if the Company is unable to complete the initial Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding public shares, at a per-share The Sponsor, officers and directors have agreed (i) to vote any shares owned by them in favor of any proposed Business Combination, (ii) not to redeem any shares in connection with a stockholder vote to approve a proposed initial Business Combination or sell any shares to the Company in a tender offer in connection with a proposed initial Business Combination, (iii) that the founders’ shares will not participate in any liquidating distributions from the Company’s Trust Account upon winding up if a Business Combination is not consummated. The Sponsor has agreed that it will be liable to ensure that the proceeds in the Trust Account are not reduced below $10.00 per share by the claims of target businesses or claims of vendors or other entities that are owed money by the Company for services rendered or contracted for or products sold to the Company. The agreement to be entered into by the Sponsor specifically provides for two exceptions to the indemnity it has given: it will have no liability (1) as to any claimed amounts owed to a target business or vendor or other entity, which has executed an agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account, or (2) as to any claims for indemnification by the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has it independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company believes it is unlikely that the Sponsor will be able to satisfy its indemnification obligations if it is required to do so. On December 17, 2021, the Company entered into a business combination agreement as amended on November 10, 2022, June 16, 2023, and August 4, 2023 with Rezolve Limited, a private limited company incorporated under the laws of England and Wales (“Rezolve”), Rezolve Group Limited, a Cayman Islands exempted company (“Cayman NewCo”), and Rezolve Merger Sub, Inc., (“Rezolve Merger Sub”) (such business combination agreement, the “Business Combination Agreement,” and such business combination, the “Business Combination”). On November 10, 2022, the Company and Rezolve entered into a First Amendment to the Business Combination Agreement (the “Amendment,” and together with the Original Business Combination Agreement, the “Business Combination Agreement” and the business combination contemplated thereby, the “Business Combination”), to among other things, extend the date on which either party to the Business Combination Agreement had the right to terminate the Business Combination Agreement if the Business Combination had not been completed by such date to the later of (i) January 31, 2023 or (ii) fifteen days prior to the last date on which the Company may consummate a Business Combination, and change the structure of the Business Combination such that Cayman NewCo is no longer a party to the Business Combination Agreement or the Business Combination. On February 2, 2023, the Company held its Annual Meeting. At the Annual Meeting, the Company’s stockholders approved an amendment to the Company’s Charter to extend the date by which the Company must consummate a Business Combination or, if it fails to do so, cease its operations and redeem or repurchase 100% of the shares of the Company’s common stock issued in the Company’s IPO, from February 17, 2023 for up to six additional months at the election of the Company, ultimately until as late as August 17, 2023 (the “Extension”). In connection with the Extension, the holders of 11,491,148 shares of Common Stock elected to redeem their shares at a per share redemption price of approximately $10.19. As a result, $117,079,879 was removed from the Company’s Trust Account to pay such holders. On June 16, 2023, the Company, Rezolve, Rezolve AI Limited, a private limited liability company incorporated under the laws of England and Wales (“Rezolve AI”) and Rezolve Merger Sub amended and restated the Business Combination Agreement (the “Amended and Restated Business Combination Agreement”) by way of a Deed of Release, Amendment and Restatement to, among other things, amend (a) the enterprise value of Rezolve by which the aggregate stock consideration is calculated to $1.60 billion, and (b) provide for (i) a pre-Closing Pre-Closing Pre-Closing Concurrently with the execution and delivery of the Amended and Restated Business Combination Agreement, the Company and the Key Company Shareholders (as defined in the Amended and Restated Business Combination Agreement) have entered into the Transaction Support Agreement, pursuant to which, among other things, the Key Company Shareholders have agreed to (a) vote in favor of the Company Reorganization (b) vote in favor of the Amended and Restated Business Combination Agreement and the agreements contemplated thereby and the transactions contemplated thereby, (c) enter into the Investor Rights Agreement (as defined in the Amended and Restated Business Combination Agreement) at Closing and (d) the termination of certain agreements effective as of Closing. On August 2, 2023, the Company held a special meeting of its stockholders to approve an amendment to its Charter (the “Charter Amendment”) to extend the date (the “Termination Date”) by which Armada has to consummate a Business Combination from August 17, 2023 (the “Original Termination Date”) to September 17, 2023 (the “Charter Extension Date”) and to allow Armada, without another stockholder vote, to elect to extend the Termination Date to consummate a Business Combination on a monthly basis up to five times by an additional one month each time after the Charter Extension Date, by resolution of Armada’s board of directors, if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until February 17, 2024, or a total of up to nine months after the Original Termination Date, unless the closing of a Business Combination shall have occurred prior thereto (the “Second Extension Amendment Proposal”). The stockholders of Armada approved the Second Extension Amendment Proposal at the special meeting and on August 3, 2023, Armada filed the Charter Amendment with the Delaware Secretary of State. In connection with the vote to approve the Charter Amendment, the holders of 1,145,503 public shares of Common Stock of Armada exercised their right to redeem their shares for cash at a redemption price of approximately $10.56 per share, for an aggregate redemption amount of approximately $12,095,215. In connection with the approval of the Second Extension Amendment Proposal, the Company issued an unsecured promissory note in the principal amount of up to $425,402 (the “Extension Note”) to the Sponsor. The Extension Note does not bear interest and matures upon closing of the Business Combination. In the event that Armada does not consummate a Business Combination, the Note will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The proceeds of the Extension Note will be deposited in the Trust Account in connection with the Charter Amendment as follows: $70,900 to be deposited into the Trust Account within five business days following approval of the Charter Amendment by the Company’s stockholders, and up to $354,502 in five equal installments to be deposited into the Trust Account for each of the five one-month On August 4, 2023, the Company, Rezolve, Rezolve AI, and Rezolve Merger Sub amended the Business Combination Agreement to remove the requirement that after giving effect to the transactions contemplated by the Business Combination Agreement, Rezolve shall have at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of On February 15, 2024, the Company held a special meeting of its stockholders to approve an amendment to its Charter (the “Charter Amendment”) to extend the date (the “Termination Date”) by which the Company has to consummate a Business Combination from February 17, 2024 (the “Termination Date”) to March 17, 2024 (the “Charter Extension Date”) and to allow the Company, without another stockholder vote, to elect to extend the Termination Date to consummate a Business Combination on a monthly basis up to five times by an additional one month each time after the Charter Extension Date, by resolution of the Company’s board of directors, if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until August 17, 2024, or a total of up to nine months after the Original Termination Date, unless the closing of a Business Combination shall have occurred prior thereto (the “Third Extension Amendment Proposal”). The stockholders of the Company approved the Third Extension Amendment Proposal at the special meeting and on February 15, 2024 the Company filed the Charter Amendment with the Delaware Secretary of State. In connection with the vote to approve the Charter Amendment, the holders of 945,662 shares of Common Stock of the Company exercised their right to redeem their shares for cash at a redemption price of approximately $10.98 per share, for an aggregate redemption amount of $10,384,496. In connection with the approval of the Third Extension Amendment Proposal, the Company issued an unsecured promissory note in the principal amount of up to $297,714 (the “Second Extension Note”) to the Sponsor. The Second Extension Note does not bear interest and matures upon closing of the Business Combination. In the event that the Company does not consummate a Business Combination, the Second Extension Note will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The proceeds of the Second Extension Note will be deposited in the Trust Account in connection with the Charter Amendment as follows: $49,619 to be deposited into the Trust Account within three business days following February 17, 2024, and up to $248,095 in five equal installments to be deposited into the Trust Account for each of the five one-month Liquidity and Going Concern The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. As of June 30, 2024, the Company had $13,242 of cash in its bank operating account and a working capital deficiency of approximately $10.9 million. Following the completion of our IPO, the Sponsor has from time to time provided loans to the Company in order to assist the Company to fund its working capital needs and to provide funds to pay for the extensions of the Combination Period, all as more fully described in Note 3. The aggregate balance outstanding under all promissory notes, including the Extension Note and the Second Extension Note, was $3,056,726 and $2,564,439 as of June 30, 2024, and September 30, 2023, respectively. The balance of subscription agreement liability (net of debt discount) was $354,503 as of June 30, 2024, and $0 as of September 30, 2023. In connection with the Company’s assessment of going concern considerations in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Update(“ASU”) 2014-15, “Disclosures Risks and Uncertainties Management is continuing to evaluate the impact of the COVID-19 pandemic Inflation Reduction Act of 2022 On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs on or after January 1, 2023, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of the Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with the Business Combination (or otherwise issued not in connection with the Business Combination but issued within the same taxable year of the Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. The Company has agreed that any such excise taxes shall not be paid from the interest earned on the funds held in the Trust Account. As discussed above, during February 2023, holders of 11,491,148 shares of Common Stock elected to redeem their shares in connection with the Extension. As a result, $117,079,879 was removed from the Company’s Trust Account to pay such holders. During August 2023, holders of 1,145,503 shares of Common Stock elected to redeem their shares in connection with the Second Amendment Extension Proposal. As a result, $12,095,215 was removed from the Company’s Trust Account to pay such holders. During February 2024, holders of 945,662 shares of Common Stock elected to redeem their shares in connection with the Third Amendment Extension Proposal. As a result, $10,384,496 was removed from the Company’s Trust Account to pay such holders. Management has evaluated the requirements of the IR Act and the Company’s operations, and has determined that $1,395,596 related to the redemptions as described above is required to be recorded as a liability on the Company’s balance sheet as of June 30, 2024. This liability will be reevaluated and remeasured at the end of each quarterly period. During the third quarter, the IRS issued final regulations with respect to the timing and payment of the excise tax. Pursuant to those regulations, the Company would need to file a return and remit payment for any liability incurred during the period from January 1, 2023 to December 31, 2023 on or before October 31, 2024. The Company is currently evaluating its options with respect to payment of this obligation. If the Company is unable to pay its obligation in full, it will be subject to additional interest and penalties which are currently estimated at 10% interest per annum and a 5% underpayment penalty per month or portion of a month up to 25% of the total liability for any amount that is unpaid from November 1, 2024 until paid in full.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
Significant Accounting Policies	Jun. 30, 2024
Accounting Policies [Abstract]
Significant Accounting Policies	Note 2 — Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by US GAAP. In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are necessary to present fairly the financial position, and the results of its operations and its cash flows for the period presented in the unaudited condensed financial statements. Operating results for the three and nine months ended June 30, 2024, are not necessarily indicative of the results that may be expected through September 30, 2024. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K, Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart the Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the p Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Cash The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $13,242 and $60,284 in cash as of June 30, 2024 and September 30, 2023, respectively. Cash Held in Trust Account As of both June 30, 2024, and September 30, 2023, the assets held in the Trust Account were held in an interest-bearing demand deposit account. To mitigate the risk that the Company may be deemed an investment company for purposes of the Investment Company Act, on August 10, 2023, the Company instructed the trustee of the Trust Account to liquidate the investments held in the Trust Account and thereafter to hold all funds in the Trust Account in an interest bearing demand deposit account until the earlier of consummation of a Business Combination or liquidation. Furthermore, such cash is held in bank accounts which exceed federally insured limits as guaranteed by the Federal Deposit Insurance Corporation. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The fair value of certain of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheets. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. At June 30, 2024 and September 30, 2023, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Offering Costs Associated with IPO The Company complies with the requirements of ASC340-10-S99-1and Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ deficit. The Company’s shares of common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 1,417,687 and 2,363,349 and shares of common stock as of June 30, 2024 and September 30, 2023 subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. The Company recognizes changes in redemption value as they occur. Immediately upon the closing of the IPO, the Company recognized the remeasurement adjustment from initial carrying amount to redemption book value. The change in the carrying value of common stock subject to possible redemption resulted in charges against additional paid-in At June 30, 2024 and September 30, 2023, the common stock reflected in the balance sheets are reconciled in the following table: Gross Proceeds $ 150,000,000 Proceeds allocated to Public Warrants (11,700,000 ) Issuance costs related to common stock (3,261,589 ) Remeasurement of carrying value to redemption value 14,961,589 Subsequent remeasurement of carrying value to redemption value – Trust interest income (excluding the amount that can be withdrawn from Trust Account for taxes) 548,862 Common stock subject to possible redemption – September 30, 2022 $ 150,548,862 Redemptions (129,175,094 ) Remeasurement of carrying value to redemption value 3,943,038 Common stock subject to possible redemption – September 30, 2023 $ 25,316,806 Redemptions (10,384,496 ) Remeasurement of carrying value to redemption value 1,108,476 Common stock subject to possible redemption – June 30, 2024 $ 16,040,786 Net (Loss) Income Per Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per common stock is computed by dividing net (loss) income by the weighted average number of common stock outstanding for the period. Remeasurement adjustments associated with the redeemable shares of common stock are excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted (loss) income per share does not consider the effect of the warrants issued in connection with the IPO because the warrants are contingently exercisable, and the contingencies have not yet been met. The warrants are exercisable to purchase 7,500,000 shares of common stock in the aggregate. As of June 30, 2024 and 2023, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net (loss) income per common stock is the same as basic net (loss) income per common stock for the periods presented. Accretion of the carrying value of common stock subject to redemption value is excluded from net (loss) income per common stock because the redemption value approximates fair value. For the Three Months Ended June 30, For the Nine Months Ended June 30, 2024 2023 2024 2023 Common subject to possible redemption Common stock Common subject to possible redemption Common stock Common subject to possible redemption Common stock Common subject to possible redemption Common stock Basic and diluted net (loss) income per share Numerator: Allocation of net (loss) income, as adjusted $ (283,071 ) $ (1,140,024 ) $ (212,999 ) $ (346,585 ) $ (539,100 ) $ (1,625,155 ) $ 12,296 $ 8,004 Denominator: Basic and diluted weighted average shares outstanding 1,417,687 5,709,500 3,508,852 5,709,500 1,893,969 5,709,500 8,770,367 5,709,500 Basic and diluted net (loss) income per share $ (0.20 ) $ (0.20 ) $ (0.06 ) $ (0.06 ) $ (0.28 ) $ (0.28 ) $ 0.00 $ 0.00 Stock-Based Compensation The Company accounts for share-based payments in accordance with FASB ASC Topic 718, “Compensation—Stock Compensation,” (“ASC 718”), which requires that all equity awards be accounted for at their “fair value.” The Company measures and recognizes compensation expense for all share-based payments on their estimated fair values measured as of the grant date. These costs are recognized as an expense in the condensed statements of operations upon vesting, once the applicable performance conditions are met, with an offsetting increase to additional paid-in On June 16, 2021, the Sponsor transferred 50,000 shares to each of its Chief Executive Officer and to its President and 35,000 shares to each of its three independent directors. The aforementioned transfer is within the scope of ASC 718. Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The aggregate fair value of these shares was $509,552 at issuance. A total of 100,000 shares vested upon consummation of the Initial Public Offering. The remaining 105,000 shares vest in equal quarterly installments until the second anniversary of the consummation of the Company’s Initial Public Offering, or August 17, 2023. At June 30, 2024, all shares under the June 16, 2021 grant were vested. On June 26, 2023, the Sponsor allocated 270,000 shares to its three independent directors (90,000 each) and 100,000 shares to an executive officer. The aforementioned transfer is within the scope of ASC 718. Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the transfer date. The aggregate fair value of these shares was $207,200 at the date of the transfer. A total of 190,000 shares vested upon the transfer date. The remaining 180,000 shares will vest as follows: 90,000 upon the 6 month anniversary of the transfer date; and 90,000 upon the one year anniversary of the transfer date, provided that all unvested shares would become vested upon consummation of initial business combination. The Company recognized $100,800 of stock-based compensation related to this grant for the nine months ended June 30, 2024. On April 18, 2024, the Chief Executive Officer and President of the Company each purchased 75,000 Founder Shares (or an aggregate of 150,000 shares) from other members of the Sponsor for $.006 per share or a total of $900. The Sponsor allocated these Founder Shares from the selling members to the Chief Executive Officer and President. The aforementioned transfer is within the scope of ASC 718. Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the transfer date. The excess of the fair value of the shares purchased by executives over the price that they paid for these shares is recorded as part of the stock compensation expense in the Company’s statement of operations. The Company recognized $601,809 and $190,289 of stock-based compensation for the nine-month periods ended June 30, 2024 and June 30, 2023, respectively and $526,209 and $134,363 of stock-based compensation for the three month periods ended June 30, 2024 and 2023, respectively. Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not As of June 30, 2024, and September 30, 2023, the Company’s deferred tax asset had a full valuation allowance recorded against it. Our effective tax rate was (2.77)% and (17.26) % for the three months ended June 30, 2024 and 2023. Our effective tax rate was (7.62)% and 96.28% for the nine months ended June 30, 2024 and 2023. The effective tax rate differs from the statutory tax rate of 21 % for the three and nine months ended June 30, 2024, and 2023, due to the valuation allowance on the deferred tax assets and permanent differences related to the business acquisition, stock-based compensation expenses and non-deductible interest. While ASC 740 identifies usage of an effective annual tax rate for purposes of an interim provision, it does allow for estimating individual elements in the current period if they are significant, unusual or infrequent. Computing the effective tax rate for the Company is complicated due to the potential impact of the timing of any Business Combination expenses and the actual interest income that will be recognized during the year. The Company has taken a position as to the calculation of income tax expense in a current period based on ASC 740-270-25-3 which states, “If an entity is unable to estimate a part of its ordinary income (or loss) or the related tax (benefit) but is otherwise able to make a reasonable estimate, the tax (or benefit) applicable to the item that cannot be estimated shall be reported in the interim period in which the item is reported.” The Company believes its calculation to be a reliable estimate and allows it to properly take into account the usual elements that can impact its annualized book income and its impact on the effective tax rate. As such, the Company is computing its taxable income (loss) and associated income tax provision based on actual results through June 30, 2024. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2024, and September 30, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Debt Discounts Debt discounts represent issuance costs related to subscription agreement liability, and are included in the condensed consolidated balance sheets as a direct deduction from the face amount of the subscription agreement liability. Debt discounts are amortized over the term of the related subscription agreements and are included in the interest expense. Recent Accounting Pronouncements In December 2023, the FASB issued ASU 2023-09, 2023-09)”, 2023-09 2023-09

Related Party Transactions

Related Party Transactions	9 Months Ended
Related Party Transactions	Jun. 30, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Note 3 — Related Party Transactions Founder Shares On February 3, 2021, the Sponsor paid $25,000, approximately $0.006 per share, to cover certain offering costs in consideration for 4,312,500 shares of common stock, par value $0.0001. On June 16, 2021, the Sponsor purchased an additional 700,000 shares of common stock at a purchase price of $0.006 per share, or an aggregate $4,070, and transferred 50,000 shares to its Chief Executive Officer and to its President and 35,000 shares to each of its three independent directors. On July 23, 2021, the Sponsor purchased an additional 1,200,000 shares of common stock at a purchase price of $0.006 per share, or an aggregate $6,975, resulting in the Sponsor holding an aggregate of 6,007,500 shares of common stock and the Chief Executive Officer, President and independent directors holding an aggregate of 205,000 shares of common stock (such shares, collectively, the “Founder Shares”). The Founder Shares included an aggregate of up to 1,125,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option was not exercised in full or in part. On October 1, 2021 the underwriters’ over-allotment option expired unused resulting in 1,125,000 Founder Shares forfeited to the Company for no consideration. The Sponsor, officers and directors have agreed not to transfer, assign or sell any Founder Shares held by them until the earliest of (A)180 days after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, the date on which the Company completes a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of the public stockholders having the right to exchange their public shares for cash, securities or other property (except with respect to permitted transferees). Any permitted transferees would be subject to the same restrictions and other agreements of the Sponsor, officers, and directors with respect to any Founder Shares. Additionally, upon consummation of the IPO, the Sponsor sold membership interests in the Sponsor to 10 anchor investors that purchased 9.9% of the units sold in the IPO. The Sponsor sold membership interests in the Sponsor entity reflecting an allocation of 131,250 Founder Shares to each anchor investor, or an aggregate of 1,312,500 Founder Shares to all 10 anchor investors, at a purchase price of approximately $0.006 per share. The Company estimated the aggregate fair value of these founder shares attributable to each anchor investor to be $424,491, or $3.23 per share. The Company has offset the excess of the fair value against the gross proceeds from these anchor investors as a reduction in its additional paid-in Representative Common Stock On February 8, 2021, EarlyBirdCapital, Inc. and Northland Securities, Inc. (“Northland”) purchased 162,500 and 87,500 shares of common stock (“representative shares”), respectively, at an average purchase price of approximately $0.0001 per share, or an aggregate purchase price of $25. On May 29, 2021, Northland returned 87,500 shares of common stock to the Company, for no consideration, which were subsequently cancelled. The representative shares are identical to the public shares included in the Units being sold in the IPO, except that the representative shares are subject to certain transfer restrictions, as described in more detail below. The holders of the representative shares have agreed not to transfer, assign or sell any such shares until 30 days after the completion of an initial Business Combination. In addition, the holders of the representative shares have agreed (i) to waive their redemption rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of an initial Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete an initial Business Combination. Promissory Notes-to On May 9, 2022, the Sponsor loaned the Company the aggregate amount of $483,034 in order to assist the Company to fund its working capital needs. The loan is evidenced by two promissory notes in the aggregate principal amount of $483,034 from the Company, as maker, to the Sponsor, as payee. During July 2022, the Company fully repaid one of the promissory notes in the amount of $187,034, which represented monies loaned to the Company for the payment of Delaware franchise taxes. The Company utilized the interest earned on the Trust Account to repay the promissory note. The Company also paid $0 and $4,300 on behalf of the Sponsor for tax services in the three and nine-month periods ended June 30, 2024 and 2023, respectively. These amounts were applied against the balance owing to the Sponsor under the remaining promissory note. As of June 30, 2024 and September 30, 2023, the net amount outstanding under the promissory note was $247,454 and $247,454, respectively. On November 10, 2022, the Sponsor loaned the Company $1,500,000 in order to cover the additional contribution to the Trust Account in connection with the Company’s exercise of the extension of the Combination Period until February 17, 2023, and $450,000 to fund its working capital needs. The promissory notes are non-interest On July 28, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $125,245. The promissory note is non-interest On August 2, 2023, the Company entered into a promissory note to the Sponsor in the amount of up to $425,402. The Extension Note is non-interest On August 8, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $20,840 to be used for working capital. The promissory note is non-interest On September 8, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $79,099 to be used for working capital. The promissory note is non-interest On October 10, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $59,099 to be used for working capital. The promissory note is non-interest On November 20, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $12,510 to be used for working capital. The promissory note is non-interest On December 19, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $39,100 to be used for working capital. The promissory note is non-interest On January 16, 2024, the Company borrowed an additional $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to February 17, 2024. The funds made available by the Sponsor to the Company under the Extension Note were attributable to a draw down under the Subscription Agreement with Polar described in Note 4 below. On January 16, 2024, the Company borrowed $39,100 from the Sponsor to be used for working capital. The promissory note is non-interest In connection with the approval of the Third Extension Amendment Proposal, the Company issued an unsecured promissory note in the principal amount of up to $297,714 (the “Second Extension Note”) to the Sponsor. The Second Extension Note does not bear interest and matures upon closing of the Business Combination. In the event that the Company does not consummate a Business Combination, the Second Extension Note will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The proceeds of the Second Extension Note will be deposited in the Trust Account in connection with the Charter Amendment as follows: $ 49,619 to be deposited into the Trust Account within three business days following February 17, 2024, and up to $248,095 in five equal installments to be deposited into the Trust Account for each of the five one-month On February 16, 2024, the Company borrowed $49,619 under the Second Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to March 17, 2024. The funds made available by the Sponsor to the Company under the Second Extension Note were attributable to a draw down under the Subscription Agreement with Polar described in Note 4 below. On February 16, 2024, the Company borrowed $60,381 from the Sponsor to be used for working capital. The promissory note is non-interest On March 13, 2024, the Company borrowed $49,619 under the Second Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to April 17, 2024. The funds made available by the Sponsor to the Company under the Second Extension Note were attributable to the fourth and final draw down under the Subscription Agreement with Polar described in Note 4 below. On March 13, 2024, the Company borrowed $60,381 from the Sponsor to be used for working capital. The promissory note is non-interest On April 16, 2024, the Company borrowed $49,619 under the Second Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to May 17, 2024. On April 16, 2024 the Company issued a promissory note to the Sponsor for the aggregate amount of $53,388 to be used for working capital. The promissory note is non-interest On April 22, 2024 the Company issued a promissory note to the Sponsor for the aggregate amount of $40,939 to be used for working capital. The promissory note is non-interest On April 25, 2024 the Company issued a promissory note to the Sponsor for the aggregate amount of $19,054 to be used for working capital. The promissory note is non-interest On May 15, 2024, the Company borrowed $49,619 under the Second Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to June 17, 2024. On May 15, 2024, the Company issued a promissory note to the Sponsor for the aggregate amount of $12,381 to be used for working capital. The promissory note is non-interest On June 6, 2024, the Company issued a promissory note to the Sponsor for the aggregate amount of $5,150 to be used for working capital. The promissory note is non-interest On June 15, 2024, the Company borrowed $49,619 under the Second Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to July 17, 2024. On June 21, 2024, the Company issued a promissory note to the Sponsor for the aggregate amount of $1,364 to be used for working capital. The promissory note is non-interest On June 21, 2024, the Company issued a promissory note to the Sponsor for the aggregate amount of $32,000 to be used for working capital. The promissory note is non-interest The aggregate balance outstanding under all promissory notes, excluding the funding under the Subscription Agreements (as described in Note 4 below) was $3,056,726 and $2,564,439 as of June 30, 2024 and September 30, 2023, respectively. Administrative Service Fee Commencing on the date of the IPO, the Company will pay the Sponsor $10,000 per month for office space, utilities and secretarial support. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. For the three and nine months ended June 30, 2024, the Company incurred $30,000 and $90,000 , respectively in administrative service fees. For each of the three and nine months ended June 30, 2023, the Company incurred and paid $ 30,000 and $90,000, respectively, in administrative service fees. The Company has $60,000 and $0 related to the administrative service fees, included in the accounts payable as of June 30, 2024 and September 30, 2023, respectively.

Subscription agreement liabilit

Subscription agreement liability	9 Months Ended
Subscription agreement liability	Jun. 30, 2024
Subscription Liability [Abstract]
Subscription agreement liability	Note 4 — Subscription Agreements Liability Effective December 12, 2023, the Company and the Sponsor entered into a subscription agreement (the “Subscription Agreement”) with Polar Multi-Strategy Master Fund (“Polar”), an unaffiliated third party of the Company, pursuant to which Polar agreed to make certain capital contributions (the “Investor Capital Contribution”) from time to time, at the request of the Sponsor, subject to the terms and conditions of the Subscription Agreement, to the Sponsor to meet the Sponsor’s commitment to fund the Company’s working capital needs and extension payments. In exchange for the commitment of Polar to provide the Investor Capital Contribution, (i) the Sponsor will transfer shares of common stock, par value $0.0001 per share, to Polar at the closing of its initial business combination, as further described below; and (ii) the Company and the Sponsor have agreed jointly and severally to return the Investor Capital Contribution to the Investor at the closing of an initial business combination. The maximum aggregate Investor Capital Contribution is $440,000, with an initial Investor Capital Contribution of $110,000 available for drawdown within five (5) business days of the Subscription Agreement and the remaining amount to be available for drawdown in three equal tranches of $110,000 during January, February and March 2024. On December 19, 2023, the initial Investor Capital Contribution of $110,000 was funded to the Sponsor, on January 16, 2024, the second Investor Capital Contribution of $110,000 was funded to the Sponsor, on February 13, 2024, the third Investor Capital Contribution of $110,000 was funded to the Sponsor, and on March 13, 2024, the fourth and final Investor Capital Contribution of $110,000 was funded to the Sponsor. In exchange for the foregoing commitment of Polar to make the Investor Capital Contributions to the Sponsor, the Company agrees to, or cause the surviving entity following the closing of the Company’s initial business combination to, issue 880,000 shares of Company’s common stock. In the event that Sponsor or the Company defaults in its obligations under the terms of the Subscription Agreement with Polar and in the event that such default continues for a period of five (5) business days following written notice to the Sponsor and Company (the “Default Date”), the Company (or the surviving entity following the De-SPAC If the Company liquidates without consummating an initial business combination, neither the Company nor the Sponsor shall have any further obligation under the Subscription Agreement other than distributing to the Investor any available cash balances in their operating accounts up to the amount of the Investor Capital Contribution (subject to applicable law) excluding any funds held in the Trust Account. The shares currently held by the Sponsor in consideration for the amount that has been funded by Polar as of or prior to the closing of an initial business combination (the “Subscription Shares”). The Company or the surviving entity of the business combination shall promptly file a registration statement for resale to register the Subscription Shares after the closing of an initial business combination, but no later than 45 calendar days after the closing of business combination, and cause the registration statement to be declared effective by 150 calendar days after the closing of an initial business combination. The Subscription Shares shall be free from the lockup provisions currently applicable to these shares (for a period of 180 days following the closing of the business combination), provided that the stockholders of the Company shall have approved a proposal to such effect at the stockholders meeting held to approve the initial business combination. On April 18, 2024, the Company entered into a subscription agreement with an entity related to the Sponsor pursuant to which (i) the entity funded $33,008 to the Sponsor which is to be returned to the entity by the Sponsor promptly following the closing of the initial business combination and (ii) as an inducement for the investment, the Sponsor allocated 33,000 Founder Shares to the entity. The funds received from the entity were loaned by the Sponsor to the Company. The Company accounts for the subscription agreements liability as a bundled transaction with allocation of individual items based on their relative fair values. The fair value of shares issuable under the Subscription Agreements is considered cost of borrowing of the funds lent by the Sponsor upon receipt of the Contributions from the Investor and the net amount is recorded as subscription agreement liability in the Company’s condensed balance sheet. The Company recognized $462,716 of cost of borrowing attributable to the draws under the Subscription Agreements. Such cost of borrowing is amortized over the term of the Subscription Agreements and is included in the Company’s statement of operations as interest expense. For the nine months ended June 30, 2024, the Company recorded $344,226 of interest expense attributable to the previously recognized cost of borrowing. The net amount of subscription liability of $354,503 is presented as a separate line item in the Company’s condensed balance sheet as of June 30, 2024.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 5 — Commitments and Contingencies Registration Rights The holders of the Founder Shares issued and outstanding on the date of the IPO, as well as the holders of the representative shares, Private Shares and any shares the Sponsor may receive in payment of the Extension Note, will be entitled to registration rights pursuant to an agreement signed on the effective date of the IPO. The holders of a majority of these securities (other than the holders of the representative shares) are entitled to make up to two demands that the Company registers such securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the Private Shares and shares issued to the Sponsor in payment of the Extension Note can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s consummation of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters were paid a cash underwriting discount of 1.0% of the gross proceeds of the IPO, or $1,500,000 (and are entitled to an additional $225,000 of deferred underwriting commission payable at the time of an initial Business Combination if the underwriters’ over-allotment is exercised in full). On October 1, 2021 the underwriters’ over-allotment option expired unused resulting in the $225,000 deferred underwriting commission to be not payable to the underwriter. Financial Advisory Fee The Company has engaged Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC (“CCM”), an affiliate of a member of the Sponsor, to provide consulting and advisory services in connection with the IPO, for which it received an advisory fee equal to one (1.0) percent of the aggregate proceeds of the IPO, or $1,500,000, upon closing of the IPO. Affiliates of CCM have and manage investment vehicles with a passive investment in the Sponsor. On August 18, 2021, the Company paid to CCM an aggregate of $1,500,000. The Company engaged CCM as a capital markets advisor in connection with the initial Business Combination for which it will earn an advisory fee of $3,000,000 payable only upon closing of the Business Combination. The Company also engaged CCM as a financial advisor in connection with the initial Business Combination for which it will earn an advisory fee of $8,750,000 payable only upon closing of the Business Combination. The Company has engaged D.A. Davidson & Co. as a financial advisor and investment banker in connection with the initial Business Combination for which it will earn an advisory fee of $600,000, payable only upon closing of the Business Combination. The Company has engaged Craig Hallum Capital Group LLC as a financial advisor in connection with the initial Business Combination for which it will earn an advisory fee of $500,000, payable only upon closing of the Business Combination. The Company had engaged ICR LLC (“ICR”) to provide investor relations services in connection with the initial Business Combination for which ICR was entitled to a monthly fee of $10,400 for the period from November 2021 through December 2022 when the contract with ICR was terminated. A total of $145,600 is recorded by the Company and is due and payable to ICR upon either the termination of or the closing of the initial Business Combination. Under the contract, an additional $145,600 would be due and payable to ICR only upon the closing of the initial Business Combination. The Company has engaged Bishop IR (“Bishop”) as an investor relations advisor in connection with the initial Business Combination for the period from June 21, 2023 through June 20, 2024 with a monthly fee of $8,000, which will increase to $12,000 upon the closing of the initial Business Combination. Either party can terminate the contract at any time upon thirty days prior notice to the other party. Upon completion of initial Business Combination, Bishop would be entitled to a success fee of $100,000 payable only upon closing of the initial Business Combination. Business Combination Marketing Agreement The Company engaged Northland Securities, Inc., the representative of the underwriters, as an advisor in connection with Business Combination to assist in holding meetings with the Company’s stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with the initial Business Combination and assist the Company with press releases and public filings in connection with the Business Combination. The Company will pay the representative a cash fee for such services only upon the consummation of the initial Business Combination in an amount equal to 2.25% of the gross proceeds of the IPO, or $3,375,000. The Company will also pay the representative a separate capital market advisory fee of $2,500,000 only upon the completion of the initial Business Combination. Additionally, the Company will pay the representative a cash fee equal to 1.0% of the total consideration payable in the proposed Business Combination if the representative introduces the Company to the target business with which the Company completes a Business Combination. On February 8, 2021, Northland purchased 87,500 shares of common stock at an average purchase price of approximately $0.0001 per share. On May 29, 2021, Northland returned these 87,500 shares of common stock to the Company, for no consideration, which were subsequently cancelled. We also will pay to the representative only upon the closing of the initial Business Combination, $1,030,000 due under two separate engagement letters in connection with fairness opinions delivered to our Board of Directors. An aggregate of $120,000 has already been paid under these engagement letters and expensed in the Company’s statement of operations for the fiscal year ended September 30, 2022. Non-Redemption On January 20, 2023, the Company and its Sponsor entered into ten agreements (the “Non-Redemption Non-Redemption Non-Redemption non-redeeming paid-in Non-Redemption Right of First Refusal If the Company determines to pursue any equity, equity-linked, debt or mezzanine financing relating to or in connection with an initial Business Combination, then Northland Securities, Inc. shall have the right, but not the obligation, to act as book running manager, placement agent and/or arranger, as the case may be, in any and all such financing or financings. This right of first refusal extends from the date of the IPO until the earlier of the consummation of an initial Business Combination or the liquidation of the Trust Account if the Company fails to consummate a Business Combination during the required time period. Purchasing Agreement On February 23, 2023, Armada, Rezolve and YA II PN, Ltd., a Cayman Islands exempted company (“YA”) entered into a Standby Equity Purchase Agreement (the “Purchase Agreement”), pursuant to which, among other things, upon the closing of the Business Combination, Rezolve shall have the right to issue and sell to YA up to $250 million of the ordinary shares of Rezolve during the 36 month period following the closing of the Business Combination. Rezolve will not be obligated to draw any amount under the Agreement, will control both the timing and amount of all drawdowns, and will issue stock to YA on each drawn down from the facility. Subject to closing of the Business Combination, Rezolve must file and maintain a registration statement, or multiple registration statements, for resale by YA of the shares. If the Business Combination Agreement is terminated, other than in connection with the consummation of the Business Combination, then the Purchase Agreement shall be terminated and of no further effect, without any liability of any party thereunder. Other than making appropriate disclosure of the Purchase Agreement under the Federal securities laws, the Company has no obligations under the Purchase Agreement. On February 2, 2024, Armada, Rezolve, Rezolve AI and YA amended and restated the Purchase Agreement, (the “Amended and Restated Purchase Agreement”) to, among other things, incorporate a prepaid advance arrangement, whereby YA committed to provide Rezolve with a prepaid advance in an original principal amount of $2,500,000 (the “Prepaid Advance”). Upon execution of the Amended and Restated Purchase Agreement, $2,000,000 of the Prepaid Advance was funded to Rezolve.

Recurring Fair Value Measuremen

Recurring Fair Value Measurements	9 Months Ended
Recurring Fair Value Measurements	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Recurring Fair Value Measurements	Note 6 — Recurring Fair Value Measurements Funds in the Company’s Trust Account were held in an interest-bearing demand deposit account June 30, 2024 September 30, 2023 Level Amount Level Amount Assets: Interest-bearing demand deposit account 1 $ 16,126,337 1 $ 25,324,028

Stockholders' Deficit

Stockholders' Deficit	9 Months Ended
Stockholders' Deficit	Jun. 30, 2024
Equity [Abstract]
Stockholders' Deficit	Note 7 — Stockholders’ Deficit Preferred stock The Company is authorized to issue 1,000,000 shares of preferred stock with apar value of $0.0001 and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2024 and September 30, 2023, there were no shares of preferred stock issued or outstanding. Common stock The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. At June 30, 2024 and September 30, 2023, there were 5,709,500 shares of common stock issued and outstanding, excluding 1,417,687 and 2,363,349 shares subject to redemption, respectively. On February 3, 2021, affiliates of the Sponsor paid $25,000, or approximately $0.006 per share, to cover certain offering costs in consideration for 4,312,500 Founder Shares. On February 8, 2021, EarlyBirdCapital, Inc. and Northland purchased 162,500 and 87,500 representative shares, respectively, at an average purchase price of approximately $0.0001 per share, or an aggregate purchase price of $25.00. On May 29, 2021, Northland returned 87,500 shares of common stock to the Company, for no consideration, which were subsequently cancelled and on June 16, 2021, the Sponsor purchased an additional 700,000 shares of common stock at a purchase price of $0.006 per share, resulting in the Sponsor holding an aggregate of 5,012,500 shares of common stock. On June 16, 2021, the Sponsor transferred 50,000 shares to its Chief Executive Officer and to its President and 35,000 shares to each of its three outside directors. The Founder Shares included an aggregate of up to 1,125,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option was not exercised in full or in part. On October 1, 2021 the underwriter’s over-allotment option expired unused resulting in 1,125,000 founder shares forfeited to the Company for no consideration. Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. In connection with any vote held to approve the initial Business Combination, the Sponsor, as well as all of the Company’s officers and directors, have agreed to vote their respective shares of common stock owned by them immediately prior to the IPO and any shares purchased in the IPO or following the IPO in the open market in favor of the proposed Business Combination. Warrants Each whole warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment as discussed herein. The warrants will become exercisable 30 days after the completion of the Company’s initial Business Combination. However, no warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the public warrants is not effective within 90 days following the consummation of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. In the event of such cashless exercise, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” for this purpose will mean the average reported last sale price of the shares of common stock for the 5 trading days ending on the trading day prior to the date of exercise. The warrants will expire on the fifth anniversary of the completion of an initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. The Company may call the warrants for redemption, in whole and not in part, at a price of $0.01 per warrant, in whole and not in part: • at any time after the warrants become exercisable, • upon not less than 30 days’ prior written notice of redemption to each warrant holder • if, and only if, the reported last sale price of the common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations) for any 20 trading days within a 30-trading • if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants. If the Company calls the warrants for redemption as described above, the Company’s management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” for this purpose shall mean the average reported last sale price of the shares of common stock for the 5 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor, initial stockholders or their affiliates, without taking into account any founders’ shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the Market Value is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional shares of common stock or equity-linked securities.

Subsequent Events

Subsequent Events	9 Months Ended
Subsequent Events	Jun. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	Note 8— Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than as disclosed below, the Company did not identify any subsequent events that would have required adjustment or disclosure in these condensed financial statements. In connection with the Business Combination Agreement, on July 4, 2024, Rezolve effected a pre-Closing demerger (the “Pre-Closing Demerger”) pursuant to UK legislation under which (x) part of Rezolve’s business and assets (being all of its business and assets except for certain shares in Rezolve Information Technology (Shanghai) Co Ltd and its wholly owned subsidiary Nine Stone (Shanghai) Ltd and Rezolve Information Technology (Shanghai) Co Ltd Beijing Branch) were transferred to Rezolve AI in exchange for the issue by Rezolve AI of shares of the same classes as in Rezolve Limited for distribution among the original shareholders of Rezolve in proportion to their holdings of shares of each class in Rezolve as at immediately prior to the Pre-Closing Demerger, (y) Rezolve AI assumed the secured convertible notes issued by Rezolve and (z) Rezolvewas placed into a members’ voluntary liquidation. On July 5, 2024, the Company issued a promissory note to the Sponsor for the aggregate amount of $5,150 to be used for working capital. The promissory note is non-interest bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time. On July 17, 2024, the Company borrowed $49,619 under the Second Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to August 17, 2024. On July 17, 2024, the Company issued a promissory note to the Sponsor for the aggregate amount of $381 to be used for working capital. The promissory note is non-interest bearing and due on the earlier of: (i) the liquidation or release of all of the monies held in the Trust Account or (ii) the date on which the Company consummates an acquisition, merger or other business combination transaction involving the Company or its affiliates. The principal balance may be prepaid at any time. On August 1, 2024, the Company held a special meeting of stockholders (the “Special Meeting”) virtually to approve, among other things, the Company’s initial business combination, as more fully described in the Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission on July 10, 2024. In connection with the Special Meeting, Public Stockholders holding 1,300,391 Public Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, $14,803,608 (approximately $11.38 per share) was removed from the Trust Account to pay such holders. At the Special Meeting, the stockholders also approved a proposal to amend the Company’s second amended and restated certificate of incorporation to eliminate the limitation that the Company may not consummate a business combination to the extent the Company would have net tangible assets of less than $5,000,001, which amendment will be effective immediately prior to or upon consummation of a business combination in order to allow the Company to consummate the Business Combination irrespective of whether the Company would exceed such limitation. On August 15, 2024, subsequent to the fiscal quarter ended June 30, 2024, the fiscal quarter to which this Quarterly Report on Form 10-Q relates, the Company consummated the previously announced business combination pursuant to the Business Combination Agreement, by and among the Company, Rezolve, Rezolve AI and the other parties thereto. Upon consummation of the Business Combination, on August 15, 2024, (i) Rezolve AI effected a re-classification of its share capital whereby Rezolve AI series A shares were reclassified as ordinary shares of same class as existing ordinary shares on issue in Rezolve AI, with nominal value £0.0001 per share (the “Rezolve Ordinary Shares”), and (ii) the Company merged with and into Rezolve Merger Sub, with the Company surviving as a wholly owned subsidiary of Rezolve AI, with shareholders of the Company received Rezolve Ordinary Shares in exchange for their existing common stock of the Company and the Company warrant holders having their warrants automatically exchanged by assumption by Rezolve AI of the obligations under such warrants. In contemplation of closing of the Business combination the Company has entered into the following agreements with their vendors which were not paid in cash at the closing of the Business Combination: On July 30, 2024 the Company issued a promissory note to Northland Securities, Inc. (“Northland”) for an amount of $5,141,250 and agreed to pay interest on the principal amount outstanding from time to time from July 30, 2024 until the note is fully paid, at the rate of 10% per annum, compounded annually. The timing and repayment amounts under the note will depend on the amounts of financing raised by the Company and its direct and indirect parent companies after completion of the Business Combination. If more than (a) $25,000,000 in proceeds is raised while the note is outstanding, 50% of the outstanding principal and all accrued and unpaid interest on the note shall become immediately due and payable and (b) if more than $50,000,000 in gross proceeds is raised, all of the outstanding principal and all accrued and unpaid interest shall become immediately due and payable. In the event that the Company and its direct and indirect parent companies after completion of the Business Combination have less than $20,000,000 in cash, cash equivalents and marketable securities as of December 31, 2024, the Company may, at its option, on or before March 31, 2025, convert all but $1,135,000 into shares of the Company’s common stock at a price of $10.00 per share. In the event the Company and its direct and indirect parent companies after completion of the Business Combination have $20,000,000 or more in cash, cash equivalents and marketable securities as of any time on or prior to December 31, 2025, Northland may, at its option on or prior to June 30, 2026, sell any or all of the shares of the Company’s common stock received pursuant to the prior sentence to the Company at a price of $10.00 per share. The note was entered into in full satisfaction of the cash payments otherwise due to Northland by the Company at the time of closing and which are described above. All of the Company’s obligations under the Note were guaranteed by Rezolve and Rezolve AI. On August 14, 2024 the Company issued a promissory note to J.B.V. Financial Group, LLC (“JBV”) ) for an amount of $7,500,000 and agreed to pay interest on the principal amount outstanding from time to time from August 14, 2024 until the note is fully paid, at the rate of 4.95% per annum. The note is to be repaid in installments of $625,000 (“Amortization Payment”) beginning on January 31, 2025, and on each month end thereafter until December 31, 2025. The Company may, in its sole discretion, elect to pay all or any portion of the Amortization Payment or any interest due and payable on the maturity date in ordinary shares of Rezolve AI, with the number of such shares determined by dividing the Amortization Payment by a price per ordinary share equal to 95% of the arithmetic average of the daily VWAP for the 5 days ending on the day immediately preceding the due date of the Amortization Payment. The note was entered into in full satisfaction of the cash payments otherwise due to JBV by the Company at the time of closing and which are described above. All of the Company’s obligations under the Note were guaranteed by Rezolve and Rezolve AI. On August 14, 2024 Rezolve AI issued a promissory note to pay to Cohen & Company Financial Management LLC (the “Agent”) as an agent for the Sponsor, in the principal sum of $3,144,883.06 (the “Original Amount”), with the Original Amount, the accrued interest thereon and other amounts due and payable (unless prepaid earlier or converted into shares of common stock) on August 14, 2027 (the “Maturity Date’). The note bears interest at 4.95% per annum. Starting from January 31, 2025, upon Agent’s request, Rezolve AI shall pay the Agent the principal amount plus all of the accrued interest in increments of 1/18 of the outstanding principal amount (the “Amortization Payment”) on a date determined by Agent (a “Payment Date”) until the Original Amount has been paid in full prior to or on the Maturity Date or, if earlier, upon acceleration, of prepayment of the note in accordance with the terms of the note. At the option of the Company, the Amortization Payments shall be made in cash or in shares of common stock of Rezolve AI, based on the price described in the promissory note. From and after January 15, 2025, Agent shall have the right, at Agent’s sole option, on any business day, to convert at the conversion price described in the note all or any portion of the outstanding principal amount of the note up to an amount described in the note. The convertible note was entered into in exchange for the Sponsor’s interest in and extinguishment of its interest in the existing loans from the Sponsor to the Company exclusive of the funding by Polar under the subscription agreement which is described above. The funding by Polar was repaid by the Company to Polar at the time of closing as required by the subscription agreement with Polar.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
Significant Accounting Policies (Policies)	Jun. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by US GAAP. In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are necessary to present fairly the financial position, and the results of its operations and its cash flows for the period presented in the unaudited condensed financial statements. Operating results for the three and nine months ended June 30, 2024, are not necessarily indicative of the results that may be expected through September 30, 2024. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K,
Emerging Growth Company Status	Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart the Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the p
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash	Cash The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $13,242 and $60,284 in cash as of June 30, 2024 and September 30, 2023, respectively.
Cash Held in Trust Account	Cash Held in Trust Account As of both June 30, 2024, and September 30, 2023, the assets held in the Trust Account were held in an interest-bearing demand deposit account. To mitigate the risk that the Company may be deemed an investment company for purposes of the Investment Company Act, on August 10, 2023, the Company instructed the trustee of the Trust Account to liquidate the investments held in the Trust Account and thereafter to hold all funds in the Trust Account in an interest bearing demand deposit account until the earlier of consummation of a Business Combination or liquidation. Furthermore, such cash is held in bank accounts which exceed federally insured limits as guaranteed by the Federal Deposit Insurance Corporation.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The fair value of certain of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheets.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. At June 30, 2024 and September 30, 2023, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Offering Costs Associated with IPO	Offering Costs Associated with IPO The Company complies with the requirements of ASC340-10-S99-1and
Common Stock Subject to Possible Redemption	Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ deficit. The Company’s shares of common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 1,417,687 and 2,363,349 and shares of common stock as of June 30, 2024 and September 30, 2023 subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. The Company recognizes changes in redemption value as they occur. Immediately upon the closing of the IPO, the Company recognized the remeasurement adjustment from initial carrying amount to redemption book value. The change in the carrying value of common stock subject to possible redemption resulted in charges against additional paid-in At June 30, 2024 and September 30, 2023, the common stock reflected in the balance sheets are reconciled in the following table: Gross Proceeds $ 150,000,000 Proceeds allocated to Public Warrants (11,700,000 ) Issuance costs related to common stock (3,261,589 ) Remeasurement of carrying value to redemption value 14,961,589 Subsequent remeasurement of carrying value to redemption value – Trust interest income (excluding the amount that can be withdrawn from Trust Account for taxes) 548,862 Common stock subject to possible redemption – September 30, 2022 $ 150,548,862 Redemptions (129,175,094 ) Remeasurement of carrying value to redemption value 3,943,038 Common stock subject to possible redemption – September 30, 2023 $ 25,316,806 Redemptions (10,384,496 ) Remeasurement of carrying value to redemption value 1,108,476 Common stock subject to possible redemption – June 30, 2024 $ 16,040,786
Net (Loss) Income Per Common Stock	Net (Loss) Income Per Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per common stock is computed by dividing net (loss) income by the weighted average number of common stock outstanding for the period. Remeasurement adjustments associated with the redeemable shares of common stock are excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted (loss) income per share does not consider the effect of the warrants issued in connection with the IPO because the warrants are contingently exercisable, and the contingencies have not yet been met. The warrants are exercisable to purchase 7,500,000 shares of common stock in the aggregate. As of June 30, 2024 and 2023, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net (loss) income per common stock is the same as basic net (loss) income per common stock for the periods presented. Accretion of the carrying value of common stock subject to redemption value is excluded from net (loss) income per common stock because the redemption value approximates fair value. For the Three Months Ended June 30, For the Nine Months Ended June 30, 2024 2023 2024 2023 Common subject to possible redemption Common stock Common subject to possible redemption Common stock Common subject to possible redemption Common stock Common subject to possible redemption Common stock Basic and diluted net (loss) income per share Numerator: Allocation of net (loss) income, as adjusted $ (283,071 ) $ (1,140,024 ) $ (212,999 ) $ (346,585 ) $ (539,100 ) $ (1,625,155 ) $ 12,296 $ 8,004 Denominator: Basic and diluted weighted average shares outstanding 1,417,687 5,709,500 3,508,852 5,709,500 1,893,969 5,709,500 8,770,367 5,709,500 Basic and diluted net (loss) income per share $ (0.20 ) $ (0.20 ) $ (0.06 ) $ (0.06 ) $ (0.28 ) $ (0.28 ) $ 0.00 $ 0.00
Stock-Based Compensation	Stock-Based Compensation The Company accounts for share-based payments in accordance with FASB ASC Topic 718, “Compensation—Stock Compensation,” (“ASC 718”), which requires that all equity awards be accounted for at their “fair value.” The Company measures and recognizes compensation expense for all share-based payments on their estimated fair values measured as of the grant date. These costs are recognized as an expense in the condensed statements of operations upon vesting, once the applicable performance conditions are met, with an offsetting increase to additional paid-in On June 16, 2021, the Sponsor transferred 50,000 shares to each of its Chief Executive Officer and to its President and 35,000 shares to each of its three independent directors. The aforementioned transfer is within the scope of ASC 718. Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The aggregate fair value of these shares was $509,552 at issuance. A total of 100,000 shares vested upon consummation of the Initial Public Offering. The remaining 105,000 shares vest in equal quarterly installments until the second anniversary of the consummation of the Company’s Initial Public Offering, or August 17, 2023. At June 30, 2024, all shares under the June 16, 2021 grant were vested. On June 26, 2023, the Sponsor allocated 270,000 shares to its three independent directors (90,000 each) and 100,000 shares to an executive officer. The aforementioned transfer is within the scope of ASC 718. Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the transfer date. The aggregate fair value of these shares was $207,200 at the date of the transfer. A total of 190,000 shares vested upon the transfer date. The remaining 180,000 shares will vest as follows: 90,000 upon the 6 month anniversary of the transfer date; and 90,000 upon the one year anniversary of the transfer date, provided that all unvested shares would become vested upon consummation of initial business combination. The Company recognized $100,800 of stock-based compensation related to this grant for the nine months ended June 30, 2024. On April 18, 2024, the Chief Executive Officer and President of the Company each purchased 75,000 Founder Shares (or an aggregate of 150,000 shares) from other members of the Sponsor for $.006 per share or a total of $900. The Sponsor allocated these Founder Shares from the selling members to the Chief Executive Officer and President. The aforementioned transfer is within the scope of ASC 718. Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the transfer date. The excess of the fair value of the shares purchased by executives over the price that they paid for these shares is recorded as part of the stock compensation expense in the Company’s statement of operations. The Company recognized $601,809 and $190,289 of stock-based compensation for the nine-month periods ended June 30, 2024 and June 30, 2023, respectively and $526,209 and $134,363 of stock-based compensation for the three month periods ended June 30, 2024 and 2023, respectively.
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not As of June 30, 2024, and September 30, 2023, the Company’s deferred tax asset had a full valuation allowance recorded against it. Our effective tax rate was (2.77)% and (17.26) % for the three months ended June 30, 2024 and 2023. Our effective tax rate was (7.62)% and 96.28% for the nine months ended June 30, 2024 and 2023. The effective tax rate differs from the statutory tax rate of 21 % for the three and nine months ended June 30, 2024, and 2023, due to the valuation allowance on the deferred tax assets and permanent differences related to the business acquisition, stock-based compensation expenses and non-deductible interest. While ASC 740 identifies usage of an effective annual tax rate for purposes of an interim provision, it does allow for estimating individual elements in the current period if they are significant, unusual or infrequent. Computing the effective tax rate for the Company is complicated due to the potential impact of the timing of any Business Combination expenses and the actual interest income that will be recognized during the year. The Company has taken a position as to the calculation of income tax expense in a current period based on ASC 740-270-25-3 which states, “If an entity is unable to estimate a part of its ordinary income (or loss) or the related tax (benefit) but is otherwise able to make a reasonable estimate, the tax (or benefit) applicable to the item that cannot be estimated shall be reported in the interim period in which the item is reported.” The Company believes its calculation to be a reliable estimate and allows it to properly take into account the usual elements that can impact its annualized book income and its impact on the effective tax rate. As such, the Company is computing its taxable income (loss) and associated income tax provision based on actual results through June 30, 2024. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2024, and September 30, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Debt Discounts	Debt Discounts Debt discounts represent issuance costs related to subscription agreement liability, and are included in the condensed consolidated balance sheets as a direct deduction from the face amount of the subscription agreement liability. Debt discounts are amortized over the term of the related subscription agreements and are included in the interest expense.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In December 2023, the FASB issued ASU 2023-09, 2023-09)”, 2023-09 2023-09

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	9 Months Ended
Significant Accounting Policies (Tables)	Jun. 30, 2024
Accounting Policies [Abstract]
Summary of common stock reflected in the balance sheets are reconciled	At June 30, 2024 and September 30, 2023, the common stock reflected in the balance sheets are reconciled in the following table: Gross Proceeds $ 150,000,000 Proceeds allocated to Public Warrants (11,700,000 ) Issuance costs related to common stock (3,261,589 ) Remeasurement of carrying value to redemption value 14,961,589 Subsequent remeasurement of carrying value to redemption value – Trust interest income (excluding the amount that can be withdrawn from Trust Account for taxes) 548,862 Common stock subject to possible redemption – September 30, 2022 $ 150,548,862 Redemptions (129,175,094 ) Remeasurement of carrying value to redemption value 3,943,038 Common stock subject to possible redemption – September 30, 2023 $ 25,316,806 Redemptions (10,384,496 ) Remeasurement of carrying value to redemption value 1,108,476 Common stock subject to possible redemption – June 30, 2024 $ 16,040,786
Schedule of basic and diluted net loss per share	Accretion of the carrying value of common stock subject to redemption value is excluded from net (loss) income per common stock because the redemption value approximates fair value. For the Three Months Ended June 30, For the Nine Months Ended June 30, 2024 2023 2024 2023 Common subject to possible redemption Common stock Common subject to possible redemption Common stock Common subject to possible redemption Common stock Common subject to possible redemption Common stock Basic and diluted net (loss) income per share Numerator: Allocation of net (loss) income, as adjusted $ (283,071 ) $ (1,140,024 ) $ (212,999 ) $ (346,585 ) $ (539,100 ) $ (1,625,155 ) $ 12,296 $ 8,004 Denominator: Basic and diluted weighted average shares outstanding 1,417,687 5,709,500 3,508,852 5,709,500 1,893,969 5,709,500 8,770,367 5,709,500 Basic and diluted net (loss) income per share $ (0.20 ) $ (0.20 ) $ (0.06 ) $ (0.06 ) $ (0.28 ) $ (0.28 ) $ 0.00 $ 0.00

Recurring Fair Value Measurem_2

Recurring Fair Value Measurements (Tables)	9 Months Ended
Recurring Fair Value Measurements (Tables)	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Summary of fair value measurements with carrying value approximating fair value	Funds in the Company’s Trust Account were held in an interest-bearing demand deposit account June 30, 2024 September 30, 2023 Level Amount Level Amount Assets: Interest-bearing demand deposit account 1 $ 16,126,337 1 $ 25,324,028

Organization, Business Operat_2

Organization, Business Operations and Going Concern (Details Narrative) - USD ($)

1 Months Ended

9 Months Ended

12 Months Ended

Jul. 17, 2024

Jun. 17, 2024

Jun. 15, 2024

May 17, 2024

May 15, 2024

Apr. 16, 2024

Mar. 13, 2024

Feb. 17, 2024

Feb. 16, 2024

Feb. 15, 2024

Feb. 13, 2024

Feb. 09, 2024

Jan. 16, 2024

Dec. 19, 2023

Dec. 15, 2023

Nov. 09, 2023

Oct. 11, 2023

Oct. 10, 2023

Sep. 12, 2023

Aug. 08, 2023

Aug. 02, 2023

Jun. 16, 2023

Feb. 02, 2023

Jan. 20, 2023

Nov. 10, 2022

Aug. 17, 2021

Aug. 31, 2023

Jun. 30, 2024

Sep. 30, 2023

Sep. 30, 2022

Aug. 04, 2023

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Date of incorporation

Nov. 05, 2020

Transaction costs

$ 3,537,515

Underwriting commissions

1,500,000

Other offering costs

2,037,515

Proceeds held in trust account

$ 150,000,000

$ 16,126,337

$ 25,324,028

Trust assets value per unit

$ 10

Maturity period of government securities

185 days

Percentage of trust assets for acquisition

80%

Percentage of ownership for acquisition

50%

Net tangible assets for acquisition

$ 5,000,001

Extended period from IPO closing to complete acquisition

18 months

Percentage of public shares to be redeemed

100%

Interest amount to pay dissolution expenses

$ 100,000

Minimum trust proceeds per share

$ 10

Operating account

13,242

Proceeds from sale of restricted investments

$ 49,619

$ 70,900

Minimum net worth required for compliance

$ 5,000,001

Amount deposited into trust account

$ 248,095

$ 354,502

Temporary equity, accretion to redemption value

$ 1,108,476

$ 3,943,038

$ 14,961,589

Threshold date for consummation of business combination

Feb. 17, 2024

Aug. 17, 2023

Feb. 17, 2023

Number of days prior to the threhold date of completion of business combination in which the business combination agreement could be terminated

15 days

Net working capital excluding income tax and franchise tax payable

$ 10,900,000

Redemption price

$ 11.31

$ 10.71

Excise tax payable

$ 1,395,596

$ 1,291,751

Subscription Agreement [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Payment to acquire restricted investments

$ 70,900

First Amendment To The Business Combination Agreement [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Threshold date for termination of business combination agreement

Jan. 31, 2023

Common Stock [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Temporary equity, accretion to redemption value

$ 10,384,496

$ 12,095,215

Temporary equity shares redeemed during the period share

945,662

1,145,503

Redemption price

$ 10.98

$ 10.56

Unsecured Promissory Note [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Aggregate loaned amount

$ 297,714

$ 425,402

Debt instrument, interest rate, stated percentage

Tranche One [Member] | Subscription Agreement [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Proceeds from sale of restricted investments

$ 70,900

Payment to acquire restricted investments

70,900

$ 70,900

Tranche One [Member] | Extension Note [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Proceeds from sale of restricted investments

$ 70,900

Payment to acquire restricted investments

$ 49,619

$ 70,900

Tranche Two [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Payment to acquire restricted investments

70,900

Tranche Two [Member] | Subscription Agreement [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Proceeds from sale of restricted investments

70,900

Payment to acquire restricted investments

$ 49,619

$ 70,900

Tranche Two [Member] | Extension Note [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Proceeds from sale of restricted investments

$ 70,900

Payment to acquire restricted investments

$ 49,619

$ 70,900

Tranche Three [Member] | Extension Note [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Payment to acquire restricted investments

$ 49,619

Tranche Four [Member] | Extension Note [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Proceeds from sale of restricted investments

$ 70,900

Payment to acquire restricted investments

$ 49,619

$ 70,900

Tranche Five [Member] | Extension Note [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Proceeds from sale of restricted investments

$ 70,900

Payment to acquire restricted investments

$ 70,900

Approval To Extend The Last Date Prior To Which Business Combination Shall Be Consummated [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Extended date for consummation of business combination

Aug. 17, 2024

Additional extension period granted to consummate the business combination

6 months

First Of November Two Thousand And Twenty Four [Member] | Inflation Reduction Act [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Interest and penalties percentage

10%

Monthly penalty percentage for underpayment of taxes

Percentage of total tax liability for which the penalty is applicable

25%

Subsequent Event [Member] | Tranche Two [Member] | Subscription Agreement [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Payment to acquire restricted investments

$ 49,619

Subsequent Event [Member] | Tranche Five [Member] | Extension Note [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Payment to acquire restricted investments

$ 49,619

Related Party [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Note payable to related parties

$ 3,056,726

2,564,439

Subscription agreement liability

354,503

$ 0

Amended and Restated Business Combination Agreement [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Aggregate Stock Consideration

$ 1,600,000,000

Non Redemption Agreements [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Proceeds from sale of restricted investments

117,079,879

Threshold date for consummation of business combination

Aug. 17, 2023

Percentage of redeemption of public shares

100%

Temporary equity shares redeemed during the period share

11,491,148

Redemption price

$ 10.19

Excise tax payable

$ 1,395,596

IPO [Member] | Units [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Number of shares issued

15,000,000

Price per share

$ 10

Private Placement [Member] | Private Shares [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Number of shares issued

459,500

Price per share

$ 10

Private Placement [Member] | Private [Member] | Purchase Aggregate [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Aggregate purchase price

$ 4,595,000

Significant Accounting Polici_4

Significant Accounting Policies (Details Narrative)					3 Months Ended		9 Months Ended
Significant Accounting Policies (Details Narrative)	Apr. 18, 2024 USD ($) shares	Jun. 26, 2023 USD ($) shares	Aug. 17, 2021 USD ($)	Jun. 16, 2021 USD ($) Director shares	Jun. 30, 2024 USD ($) shares	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) Director shares	Jun. 30, 2023 USD ($)	Sep. 30, 2023 USD ($) shares
Cash and cash equivalents \| $					$ 13,242		$ 13,242		$ 60,284
Exceed limit \| $							$ 250,000
Shares of common stock subject to possible redemption					1,417,687		1,417,687		2,363,349
Fair value of converted shares \| $		$ 207,200		$ 509,552
Compensation expense \| $		$ 100,800
Share-Based Payment Expense \| $					$ 526,209	$ 134,363	$ 601,809	$ 190,289
Offering costs \| $			$ 3,537,515
Underwriting commissions \| $			1,500,000
Other offering costs \| $			$ 2,037,515
Effective income tax reconciliation percentage					(2.77%)	(17.26%)	(7.62%)	96.28%
Statutory tax rate percentage					21%	21%	21%	21%
Sharebased compensation arrangement by sharebased payment award options remaining number of shares vested		190,000
Share-Based Payment Arrangement, Tranche Two [Member]
Sharebased compensation arrangement by sharebased payment award options remaining number of shares vested		90,000
Share-Based Payment Arrangement, Tranche One [Member]
Sharebased compensation arrangement by sharebased payment award options remaining number of shares vested		90,000
Sponsor [Member]
Sharebased compensation arrangement by sharebased payment award options remaining number of shares vested		180,000
Founder Shares [Member] \| Sponsor [Member]
Interse transfer of shares made	150,000
Interse transfer of shares made value \| $	$ 900
President [Member]
Shares of common stock transferred				50,000
President [Member] \| Founder Shares [Member]
Interse transfer of shares received	75,000
Director [Member]
Shares of common stock transferred		90,000		35,000
Number of independent directors \| Director				3			3
Chief Executive Officer [Member] \| Founder Shares [Member]
Interse transfer of shares received	75,000
Three Independent Directors [Member]
Shares of common stock transferred		270,000
Executive Officer [Member]
Shares of common stock transferred		100,000
IPO [Member]
Share-based compensation arrangement by share-based payment award, options, vested, number of shares							100,000
Sharebased compensation arrangement by sharebased payment award options remaining number of shares vested							105,000
Warrant [Member]
Warrants exercise to purchase common stock							7,500,000

Significant Accounting Polici_5

Significant Accounting Policies - Summary of common stock reflected in the balance sheets are reconciled (Details) - USD ($)	9 Months Ended	12 Months Ended
	Jun. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Accounting Policies [Abstract]
Gross Proceeds			$ 150,000,000
Proceeds allocated to Public Warrants			(11,700,000)
Issuance costs related to common stock			(3,261,589)
Remeasurement of carrying value to redemption value	$ 1,108,476	$ 3,943,038	14,961,589
Subsequent remeasurement of carrying value to redemption value – Trust interest income (excluding the amount that can be withdrawn from Trust Account for taxes)			548,862
Common stock subject to possible redemption	16,040,786	25,316,806	$ 150,548,862
Redemptions	$ (10,384,496)	$ (129,175,094)

Significant Accounting Polici_6

Significant Accounting Policies - Schedule of basic and diluted net loss per share (Details) - USD ($)	3 Months Ended						9 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Jun. 30, 2024	Jun. 30, 2023
Allocation of net (loss) income	$ (1,423,095)	$ (380,846)	$ (360,314)	$ (559,584)	$ (27,143)	$ 607,027	$ (2,164,255)	$ 20,300
Common Stock [Member]
Allocation of net (loss) income	$ (1,140,024)			$ (346,585)			$ (1,625,155)	$ 8,004
Basic Weighted-average shares outstanding	5,709,500			5,709,500			5,709,500	5,709,500
Diluted Weighted-average shares outstanding	5,709,500			5,709,500			5,709,500	5,709,500
Basic net (loss) income per share	$ (0.2)			$ (0.06)			$ (0.28)	$ 0
Diluted net (loss) income per share	$ (0.2)			$ (0.06)			$ (0.28)	$ 0
Redeemable Common Stock [Member]
Allocation of net (loss) income	$ (283,071)			$ (212,999)			$ (539,100)	$ 12,296
Basic Weighted-average shares outstanding	1,417,687			3,508,852			1,893,969	8,770,367
Diluted Weighted-average shares outstanding	1,417,687			3,508,852			1,893,969	8,770,367
Basic net (loss) income per share	$ (0.2)			$ (0.06)			$ (0.28)	$ 0
Diluted net (loss) income per share	$ (0.2)			$ (0.06)			$ (0.28)	$ 0

Related Party Transactions (Det

Related Party Transactions (Details Narrative)

1 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

Jun. 22, 2024 USD ($)

Jun. 21, 2024 USD ($)

Jun. 17, 2024 USD ($)

Jun. 15, 2024 USD ($)

Jun. 06, 2024 USD ($)

May 15, 2024 USD ($)

Apr. 25, 2024 USD ($)

Apr. 16, 2024 USD ($)

Mar. 13, 2024 USD ($)

Feb. 17, 2024 USD ($)

Feb. 16, 2024 USD ($)

Feb. 13, 2024 USD ($)

Jan. 16, 2024 USD ($)

Dec. 19, 2023 USD ($)

Dec. 15, 2023 USD ($)

Nov. 09, 2023 USD ($)

Oct. 11, 2023 USD ($)

Oct. 10, 2023 USD ($)

Sep. 12, 2023 USD ($)

Aug. 08, 2023 USD ($)

Aug. 02, 2023 USD ($) $ / shares

Jul. 28, 2023 USD ($)

Jun. 26, 2023 shares

Nov. 10, 2022 USD ($)

Oct. 02, 2021 shares

Aug. 17, 2021 USD ($) Investor $ / shares shares

Jul. 23, 2021 USD ($) $ / shares shares

Jun. 16, 2021 USD ($) Director $ / shares shares

May 29, 2021 shares

Feb. 08, 2021 USD ($) $ / shares shares

Feb. 03, 2021 USD ($) $ / shares shares

Jul. 31, 2022 USD ($)

Jun. 30, 2024 USD ($) $ / shares

Jun. 30, 2023 USD ($)

Jun. 30, 2024 USD ($) Director $ / shares shares

Jun. 30, 2023 USD ($)

Sep. 30, 2023 USD ($) $ / shares

Apr. 22, 2024 USD ($)

Apr. 18, 2024 USD ($)

Feb. 15, 2024 USD ($)

Nov. 20, 2023 USD ($)

Sep. 08, 2023 USD ($)

May 09, 2022 USD ($)

Oct. 01, 2021 shares

Related Party Transaction [Line Items]

Common stock, par value | $ / shares

$ 0.0001

Underwriters over-allotment option expired | shares

1,125,000

Payment for administrative fees

$ 60,000

$ 0

Amount deposited into trust account

$ 248,095

$ 354,502

Proceeds from sale of restricted investments

49,619

70,900

Administrative fees expense

$ 30,000

90,000

$ 90,000

Subscription Agreement [Member]

Related Party Transaction [Line Items]

Payment to acquire restricted investments

$ 70,900

Tranche One [Member] | Subscription Agreement [Member]

Related Party Transaction [Line Items]

Proceeds from sale of restricted investments

$ 70,900

Payment to acquire restricted investments

70,900

$ 70,900

Tranche One [Member] | Extension Note [Member]

Related Party Transaction [Line Items]

Proceeds from sale of restricted investments

$ 70,900

Payment to acquire restricted investments

$ 49,619

70,900

Tranche Two [Member]

Related Party Transaction [Line Items]

Payment to acquire restricted investments

70,900

Tranche Two [Member] | Subscription Agreement [Member]

Related Party Transaction [Line Items]

Proceeds from sale of restricted investments

70,900

Payment to acquire restricted investments

$ 49,619

70,900

Tranche Two [Member] | Extension Note [Member]

Related Party Transaction [Line Items]

Proceeds from sale of restricted investments

$ 70,900

Payment to acquire restricted investments

49,619

$ 70,900

Tranche Four [Member] | Extension Note [Member]

Related Party Transaction [Line Items]

Proceeds from sale of restricted investments

$ 70,900

Payment to acquire restricted investments

$ 49,619

$ 70,900

70,900

Tranche Five [Member] | Extension Note [Member]

Related Party Transaction [Line Items]

Proceeds from sale of restricted investments

$ 70,900

Payment to acquire restricted investments

$ 70,900

Second Extension Note [Member]

Related Party Transaction [Line Items]

Debt instrument, interest rate, stated percentage

Trust Account Contribution [Member]

Related Party Transaction [Line Items]

Proceeds from related party debt

$ 1,500,000

Working Capital Needs Funding [Member]

Related Party Transaction [Line Items]

Proceeds from related party debt

$ 450,000

Polar Multi Strategy Master Fund [Member] | Extension Note [Member]

Related Party Transaction [Line Items]

Aggregate loaned amount

70,900

Sponsor [Member]

Related Party Transaction [Line Items]

Notes payable current

3,056,726

2,564,439

Aggregate loaned amount

$ 483,034

Payment for services

$ 4,300

Notes Issued

$ 32,000

$ 1,364

$ 5,150

$ 12,381

$ 19,054

Sponsor [Member] | Subscription Agreement [Member]

Related Party Transaction [Line Items]

Aggregate loaned amount

$ 39,100

$ 33,000

Sponsor [Member] | Extension Note [Member]

Related Party Transaction [Line Items]

Line of Credit Facility, Maximum Amount Outstanding During Period

354,502

Sponsor [Member] | Working Capital Loan [Member]

Related Party Transaction [Line Items]

Aggregate loaned amount

$ 60,381

$ 39,100

Sponsor [Member] | Subscription Agreement With Polar [Member]

Related Party Transaction [Line Items]

Notes payable current

39,100

Sponsor [Member] | Promissory Notes [Member]

Related Party Transaction [Line Items]

Notes payable current

247,454

Aggregate loaned amount

$ 53,388

$ 425,402

$ 125,245

$ 40,939

Repayments of debt

$ 187,034

Promissory note outstanding

125,245

Debt instrument interest rate during period

Sponsor [Member] | Promissory Notes [Member] | Working Capital Loan Tranche August Two Thousand And Twenty Three [Member]

Related Party Transaction [Line Items]

Notes payable current

20,840

Aggregate loaned amount

$ 20,840

Sponsor [Member] | Promissory Notes [Member] | Working Capital Loan Tranche September Two Thousand And Twenty Three [Member]

Related Party Transaction [Line Items]

Notes payable current

79,099

Aggregate loaned amount

$ 79,099

Sponsor [Member] | Promissory Notes [Member] | Working Capital Loan Tranche October Two Thousand And Twenty Three [Member]

Related Party Transaction [Line Items]

Notes payable current

59,099

Aggregate loaned amount

$ 59,099

Sponsor [Member] | Promissory Notes [Member] | Working Capital Loan Tranche November Two Thousand And Twenty Three [Member]

Related Party Transaction [Line Items]

Notes payable current

12,510

Aggregate loaned amount

$ 12,510

Sponsor [Member] | Promissory Notes [Member] | Common Stock [Member] | Extension Note [Member]

Related Party Transaction [Line Items]

Loan conversion price | $ / shares

$ 10

Debt conversion converted instrument amount

$ 425,402

Sponsor [Member] | Second Extension Note [Member]

Related Party Transaction [Line Items]

Aggregate loaned amount

$ 297,714

Proceeds from sale of restricted investments

49,619

Line of Credit Facility, Maximum Amount Outstanding During Period

248,095

Related Party [Member]

Related Party Transaction [Line Items]

Notes payable current

$ 3,056,726

3,056,726

$ 2,564,439

Monthly fee

$ 10,000

Related Party [Member] | Promissory Notes [Member]

Related Party Transaction [Line Items]

Notes payable current

$ 483,034

Related Party [Member] | Second Extension Note [Member]

Related Party Transaction [Line Items]

Amount deposited into trust account

$ 248,095

President [Member]

Related Party Transaction [Line Items]

Conversion of Stock, Shares Converted | shares

50,000

Director [Member]

Related Party Transaction [Line Items]

Conversion of Stock, Shares Converted | shares

90,000

35,000

Number of independent directors | Director

Chief Executive Officer [Member]

Related Party Transaction [Line Items]

Shares subject to forfeiture | shares

6,007,500

Founder Shares [Member]

Related Party Transaction [Line Items]

Value of shares issued

$ 25,000

Price per share | $ / shares

$ 0.006

Number of shares issued | shares

1,200,000

700,000

4,312,500

Common stock, par value | $ / shares

$ 0.0001

Aggregate purchase price

$ 6,975

$ 4,070

Period after business combination for transfer of shares

180 days

Stock allocated to each anchor investor, shares | shares

131,250

Stock allocated to anchor investors, shares | shares

1,312,500

Stock allocated to each anchor investor, value

$ 424,491

Stock allocated to each anchor investor, value per share | $ / shares

$ 3.23

Founder Shares [Member] | Over-Allotment Option [Member]

Related Party Transaction [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares

1,125,000

Underwriters over-allotment option expired | shares

1,125,000

Founder Shares [Member] | Chief Executive Officer President and Independent Directors [Member]

Related Party Transaction [Line Items]

Shares subject to forfeiture | shares

205,000

Units [Member]

Related Party Transaction [Line Items]

Number of anchor investors | Investor

Units [Member] | IPO [Member]

Related Party Transaction [Line Items]

Price per share | $ / shares

$ 10

Number of shares issued | shares

15,000,000

Percentage of units purchased by anchor investors

9.90%

Representative Shares [Member]

Related Party Transaction [Line Items]

Price per share | $ / shares

$ 0.0001

Period after business combination for transfer of shares

30 days

Issuance of representative

$ 25

Representative Shares [Member] | EarlyBirdCapital, Inc. [Member]

Related Party Transaction [Line Items]

Issuance of representative shares, shares | shares

162,500

Representative Shares [Member] | Northland Securities, Inc. [Member]

Related Party Transaction [Line Items]

Issuance of representative shares, shares | shares

87,500

Subscription agreement liabil_2

Subscription agreement liability (Details Narrative) - USD ($)		9 Months Ended
	Dec. 12, 2023	Jun. 30, 2024	Apr. 18, 2024	Mar. 13, 2024	Feb. 13, 2024	Dec. 19, 2023	Sep. 30, 2023	May 09, 2022
Subscription Liability [Line Items]
Subscription agreement liability, net		$ 354,503					$ 0
Common stock par or stated value per share		$ 0.0001					$ 0.0001
Cost of borrowing		$ 462,716
Interest expense		$ 344,226
Subscription Agreement [Member] \| Polar Multi Strategy Master Fund [Member]
Subscription Liability [Line Items]
Common stock par or stated value per share	$ 0.0001
Common stock subscribed but not issued value	$ 440,000
Common stock subscribed but not issued shares	880,000
Time limit from the date of consummation of business combination within which the shares shall be registered	45 days
Time limit for the registration statement to become effective from the date of consummation of business combination	150 days
Lock in period of shares	180 days
Maximum time period for default to be rectified	5 days
Subscription Agreement [Member] \| Polar Multi Strategy Master Fund [Member] \| December Two Thousand And Twenty Three [Member]
Subscription Liability [Line Items]
Common stock subscribed but not issued value	$ 110,000
Number of days within which investor shall contribute capital	5 days
Subscription Agreement [Member] \| Polar Multi Strategy Master Fund [Member] \| January Two Thousand And Twenty Four [Member]
Subscription Liability [Line Items]
Common stock subscribed but not issued value	$ 110,000
Subscription Agreement [Member] \| Polar Multi Strategy Master Fund [Member] \| February Two Thousand And Twenty Four [Member]
Subscription Liability [Line Items]
Common stock subscribed but not issued value						$ 110,000
Subscription Agreement [Member] \| Polar Multi Strategy Master Fund [Member] \| March Two Thousand And Twenty Four [Member]
Subscription Liability [Line Items]
Common stock subscribed but not issued value				$ 110,000	$ 110,000	110,000
Subscription Agreement [Member] \| Polar Multi Strategy Master Fund [Member] \| Default Shares [Member]
Subscription Liability [Line Items]
Common stock subscribed but not issued shares	220,000
Subscription Agreement [Member] \| Polar Multi Strategy Master Fund [Member] \| Additional Default Shares [Member]
Subscription Liability [Line Items]
Common stock subscribed but not issued shares	220,000
Sponsor [Member]
Subscription Liability [Line Items]
Debt instrument, face amount								$ 483,034
Sponsor [Member] \| Subscription Agreement [Member]
Subscription Liability [Line Items]
Shared allocated by sponsor			33,008
Debt instrument, face amount			$ 33,000			$ 39,100

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)

9 Months Ended

12 Months Ended

14 Months Ended

Feb. 02, 2024

Aug. 02, 2023

Feb. 23, 2023

Feb. 02, 2023

Jan. 20, 2023

Oct. 02, 2021

Aug. 18, 2021

Aug. 17, 2021

May 29, 2021

Feb. 08, 2021

Jun. 30, 2024

Jun. 20, 2024

Sep. 30, 2022

Dec. 31, 2022

Sep. 30, 2023

Underwriting discount percentage

Underwriting commissions

$ 1,500,000

Deferred underwriting commission payable

$ 225,000

Deferred underwriting commission expired

$ 225,000

Advisory fee percentage for initial public offering

Advisory fee for IPO amount if underwriters' option is not exercised

$ 1,500,000

Advisory fee paid

$ 1,500,000

Advisory fee for business combination amount if underwriters' option is not exercised

$ 3,000,000

Marketing agreement fee percentage for business combination

2.25%

Marketing agreement fee for business combination amount if underwriters' option is not exercised

$ 3,375,000

Capital market advisory fee for business combination

$ 2,500,000

Cash fee percentage for target business introduction in business combination

Long term purchase commitment amount paid

$ 120,000

Long-Term Purchase Commitment, Amount

$ 1,030,000

Threshold Date For Consummation Of Business Combination

Feb. 17, 2024

Aug. 17, 2023

Feb. 17, 2023

Redemption price

$ 11.31

$ 10.71

ICR LLC [Member]

Related party transaction, amounts of transaction monthly fee

$ 10,400

Representative Shares [Member]

Shares Issued, Price Per Share

$ 0.0001

Northland Securities, Inc. [Member] | Representative Shares [Member]

Stock Issued During Period, Shares, Other

87,500

Hallum Capital Group LLC [Member]

Advisory fee payable on consummation of business combination

$ 500,000

D A Davidson And Co [Member]

Advisory fee payable on consummation of business combination

600,000

Termination or Closing of Initial Business Combination [Member] | ICR LLC [Member]

Other liabilities

145,600

Additional Liabilities Upon the Closing of the Initial Business Combination [Member] | ICR LLC [Member]

Other liabilities

145,600

Initial Business Combination [Member] | Bishop IR [Member]

Success Fee Payable

$ 100,000

Related party transaction, amounts of transaction monthly fee

$ 8,000

Maximum [Member] | Initial Business Combination [Member] | Bishop IR [Member]

Related party transaction, amounts of transaction monthly fee

$ 12,000

Prepaid Advance Agreement [Member]

Proceeds from other debts

$ 2,000,000

Other commitement

$ 2,500,000

Amended and Restated Business Combination Agreement [Member]

Advisory fee for business combination amount if underwriters' option is not exercised

$ 8,750,000

Purchase Agreement [Member] | YA II PN, Ltd. [Member]

Value of ordinary shares expected to issue

$ 250,000,000

Non Redemption Agreements [Member]

Threshold Date For Consummation Of Business Combination

Aug. 17, 2023

Redemption price

$ 10.19

Temporary equity shares redeemed during the period shares

11,491,148

Number of Shares Allocated in Exchange for Non Redeemption of Public Shares

75,000

Non Redemption Agreements [Member] | Sponsor [Member]

Redemption price

$ 1.55

Temporary Equity Shares Redeemed During the Period Value

$ 1,102,909

Temporary equity shares redeemed during the period shares

713,057

Recurring Fair Value Measurem_3

Recurring Fair Value Measurements - Summary of fair value measurements with carrying value approximating fair value (Details) - USD ($)	Jun. 30, 2024	Sep. 30, 2023
Fair Value, Recurring [Member] \| Fair Value, Inputs, Level 1 [Member]
Disclosure In Tabular Form Of Debt Securities Trading Fair Value To Amortized Cost [Line Items]
Interest-bearing demand deposit account	$ 16,126,337	$ 25,324,028

Stockholders' Deficit (Details

Stockholders' Deficit (Details Narrative)											9 Months Ended
Stockholders' Deficit (Details Narrative)	Jun. 26, 2023 shares	Oct. 02, 2021 shares	Jul. 23, 2021 $ / shares shares	Jun. 16, 2021 Director $ / shares shares	May 29, 2021 shares	May 29, 2021 shares	Feb. 08, 2021 $ / shares shares	Feb. 08, 2021 $ / shares shares	Feb. 03, 2021 USD ($) $ / shares shares	Feb. 03, 2021 USD ($) $ / shares shares	Jun. 30, 2024 Director $ / shares shares	Sep. 30, 2023 $ / shares shares	Aug. 17, 2021 $ / shares
Class of Stock [Line Items]
Preferred stock, shares authorized											1,000,000	1,000,000
Preferred stock, par value \| $ / shares											$ 0.0001	$ 0.0001
Preferred stock, shares issued											0	0
Preferred stock, shares outstanding											0	0
Common stock, shares authorized											100,000,000	100,000,000
Common stock, par value \| $ / shares											$ 0.0001	$ 0.0001
Common stock, shares issued											5,709,500	5,709,500
Common stock, shares outstanding											5,709,500	5,709,500
Shares subject to redemption											1,417,687	2,363,349
Number of Shares Forfeited											1,125,000
Common Stock, Voting Rights											one vote for each share
Warrant exercise price \| $ / shares											$ 11.5
Warrant exercisable period after business combination											30 days
Warrant cashless exercise period after business combination											90 days
Period of trading days to determine fair market value of common stock											5 days
Warrants redemption price per share \| $ / shares											$ 0.01
Notice period for warrants redemption											30 days
Common stock share price per share for warrants redemption \| $ / shares											$ 18
Period of trading days within specified window for minimum common stock price for warrants redemption											20 days
Trading days specified window for minimum common stock price for warrants redemption											30 days
Common stock issue price per share below which triggers warrant adjustment \| $ / shares											$ 9.2
Percentage of available equity proceeds below specified price which triggers warrant adjustment											60%
Common stock market value per share below which triggers warrant adjustment \| $ / shares											$ 9.2
Percentage of Market Value for warrant exercise price adjustment											115%
President [Member]
Class of Stock [Line Items]
Shares of common stock transferred				50,000
Director [Member]
Class of Stock [Line Items]
Shares of common stock transferred	90,000			35,000
Number of independent directors \| Director				3							3
Founder Shares [Member]
Class of Stock [Line Items]
Common stock, par value \| $ / shares									$ 0.0001	$ 0.0001
Value of shares issued \| $										$ 25,000
Price per share \| $ / shares			$ 0.006	$ 0.006					$ 0.006	$ 0.006			$ 0.006
Number of shares issued			1,200,000	700,000						4,312,500
Founder Shares [Member] \| Over-Allotment Option [Member]
Class of Stock [Line Items]
Number of Shares Forfeited		1,125,000
Founder Shares [Member] \| Sponsor [Member]
Class of Stock [Line Items]
Common stock, shares outstanding				5,012,500
Founder Shares 1 [Member]
Class of Stock [Line Items]
Value of shares issued \| $									$ 25,000
Price per share \| $ / shares									$ 0.006	$ 0.006
Number of shares issued									4,312,500
Representative Shares [Member]
Class of Stock [Line Items]
Price per share \| $ / shares							$ 0.0001	$ 0.0001
Representative shares returned to the Company, shares								25
Representative Shares [Member] \| EarlyBirdCapital, Inc. [Member]
Class of Stock [Line Items]
Issuance of Representative shares, shares							162,500
Representative Shares [Member] \| Northland Securities, Inc. [Member]
Class of Stock [Line Items]
Issuance of Representative shares, shares					87,500	87,500	87,500
Representative shares returned to the Company, shares						87,500

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)

Aug. 14, 2024 USD ($) Day

Aug. 01, 2024 USD ($) $ / shares shares

Jul. 30, 2024 USD ($) $ / shares

Jul. 17, 2024 USD ($)

Jul. 05, 2024 USD ($)

Jun. 22, 2024 USD ($)

Jun. 21, 2024 USD ($)

Jun. 15, 2024 USD ($)

Jun. 06, 2024 USD ($)

May 15, 2024 USD ($)

Apr. 25, 2024 USD ($)

Apr. 16, 2024 USD ($)

Mar. 13, 2024 USD ($)

Feb. 16, 2024 USD ($)

Jan. 16, 2024 USD ($)

Dec. 19, 2023 USD ($)

Aug. 15, 2024 € / shares

Apr. 18, 2024 USD ($)

May 09, 2022 USD ($)

Tranche Two [Member]

Subsequent Event [Line Items]

Payment to acquire restricted investments

$ 70,900

Subscription Agreement [Member]

Subsequent Event [Line Items]

Payment to acquire restricted investments

70,900

Subscription Agreement [Member] | Tranche Two [Member]

Subsequent Event [Line Items]

Payment to acquire restricted investments

$ 49,619

$ 70,900

Sponsor [Member]

Subsequent Event [Line Items]

Debt instrument, face amount

$ 483,034

Notes Issued

$ 32,000

$ 1,364

$ 5,150

$ 12,381

$ 19,054

Sponsor [Member] | Subscription Agreement [Member]

Subsequent Event [Line Items]

Debt instrument, face amount

$ 39,100

$ 33,000

Subsequent Event [Member]

Subsequent Event [Line Items]

Requirement of the acquiree to have minimum net worth removed by way of resolution in a meeting

$ 5,000,001

Per share amount withdrawn from trust for redemptions | $ / shares

$ 11.38

Proceeds from trust to pay for redemptions

$ 14,803,608

Temporary equity shares subject to redemption | shares

1,300,391

Subsequent Event [Member] | Subscription Agreement [Member] | Tranche Two [Member]

Subsequent Event [Line Items]

Payment to acquire restricted investments

$ 49,619

Subsequent Event [Member] | Rezolve AI [Member] | Rezolve Ordinary Share [Member]

Subsequent Event [Line Items]

Business acquisition, share price | € / shares

€ 0.0001

Subsequent Event [Member] | Promisory Note Payable To Cohen And Company Financial Management LLC [Member] | Rezolve AI [Member]

Subsequent Event [Line Items]

Debt instrument, face amount

$ 3,144,883.06

Long term debt date after which the amount may be converted into shares

Jan. 15, 2025

Debt instrument final date of maturity

Aug. 14, 2027

Debt instrument beginning date of maturity

Jan. 31, 2025

Long term debt bearing fixed interest rate percentage

4.95%

Subsequent Event [Member] | Promissory Note Payable To JBV Financial Group [Member]

Subsequent Event [Line Items]

Debt instrument, face amount

$ 7,500,000

Debt instrument conversion price as a percentage of volume weighted average price percentage

95%

Debt instrument convertible threshold trading days | Day

Debt instrument final date of maturity

Dec. 31, 2025

Debt instrument beginning date of maturity

Jan. 31, 2025

Debt instrument periodic payment of principal

$ 625,000

Long term debt bearing fixed interest rate percentage

4.95%

Subsequent Event [Member] | Promissory note to Northland Securities, Inc. [Member]

Subsequent Event [Line Items]

Debt instrument, face amount

$ 5,141,250

Debt instrument non convertible portion of debt

1,135,000

Cash and cash equivalents threshold amount below which debt may be converted into equity

$ 20,000,000

Long term debt bearing fixed interest rate percentage

10%

Subsequent Event [Member] | Repayment Timing Tranche One [Member] | Promissory note to Northland Securities, Inc. [Member]

Subsequent Event [Line Items]

Threshold amount raised above which immediate repayment shall be made

$ 25,000,000

Percentage of outstanding amount to be repaid

50%

Subsequent Event [Member] | Repayment Timing Tranche Two [Member] | Promissory note to Northland Securities, Inc. [Member]

Subsequent Event [Line Items]

Threshold amount raised above which immediate repayment shall be made

$ 50,000,000

Subsequent Event [Member] | Debt Instrument Conversion Into Equity Tranche One [Member] | Promissory note to Northland Securities, Inc. [Member]

Subsequent Event [Line Items]

Debt instrument conversion price per share | $ / shares

$ 10

Subsequent Event [Member] | Debt Instrument Conversion Into Equity Tranche Two [Member] | Promissory note to Northland Securities, Inc. [Member]

Subsequent Event [Line Items]

Debt instrument conversion price per share | $ / shares

$ 10

Subsequent Event [Member] | Sponsor [Member]

Subsequent Event [Line Items]

Notes Issued

$ 381

$ 5,150